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Abstract
While the rise in childhood obesity is clear, the policy ramications are not. School nutrition programs such
as the School Breakfast Program (SBP) have come under much scrutiny. However, the lack of experimen-
tal evidence, combined with non-random selection into these programs, makes identication of the causal
e¤ects of such programs di¢ cult. In the case of the SBP, this di¢ culty is exacerbated by the apparent
lack of exclusion restrictions. Here, we compare via Monte Carlo study several existing estimators that do
not rely on exclusion restrictions for identication. In addition, we propose two new estimation strategies.
Simulations illustrate the usefulness of our new estimators, as well as provide applied researchers several
practical guidelines when analyzing the causal e¤ects of binary treatments. More importantly, we nd
consistent evidence of a benecial causal e¤ect of SBP participation on childhood obesity when applying
estimators designed to circumvent selection on unobservables.
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1 Introduction
Empirical researchers in economics and other disciplines are often interested in the causal e¤ect of a binary
treatment on an outcome of interest. Often randomization is used to ensure comparability (at least in
expectation) across the treatment and control groups. However, when a random experiment is not feasible
either due to ethical considerations or cost researchers must rely on non-experimental or observational
data. With such data, non-random selection of subjects into the treatment group becomes a paramount
concern.
When subjects self-select into the treatment group on the basis of attributes observable to the researcher,
there exist many statistical methods appropriate for the estimation of the causal e¤ect of the treatment.
Indeed, the econometric literature on program evaluation has witnessed profound growth in this area
over the past few decades.1 However, when subjects self-select into the treatment group on the basis of
attributes unobserved to the researcher, but correlated with the outcome of interest, the situation becomes
more di¢ cult for the researcher.
The typical strategy in such circumstances is to rely on an instrumental variable (IV) to identify the
causal e¤ect of the treatment. However, a valid instrument is often unavailable. Moreover, even if one
is available, it may identify an economically uninteresting parameter in the presence of heterogeneous
treatment e¤ects (Imbens and Angrist 1994).
This is the situation we confront in this paper. Here, we are interested in identifying the causal e¤ect
of participation in the School Breakfast Program (SBP) on childhood obesity. However, as discussed
below, we believe that students in the treatment and control groups di¤er along important observable and
unobservable dimensions. Moreover, we do not believe we have access to a strong, credible instrument.
As a result, the usual approach for dealing with non-random selection into SBP IV using an excluded
instrument does not seem viable.
To proceed, we utilize two existing estimators that do not rely on an exclusion restriction for iden-
tication: Heckmans bivariate normal selection estimator that relies on functional form assumptions for
identication and a recent IV estimator proposed by Klein and Vella (2009) that exploits heteroskedasticity
for identication. In addition, we also propose two new estimators for the analysis of binary treatments
where selection into a treatment is non-random, but one lacks an excludable instrument. The rst es-
timator entails minimizing the bias when estimating the e¤ect of a treatment using an estimator that
requires conditional independence independence between treatment assignment and potential outcomes
conditional on observables for unbiasdedness. While minimizing the bias still produces a biased estimate
1See Imbens (2004) and Imbens and Wooldridge (2009) for excellent surveys.
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of the causal e¤ect of the treatment, our second estimator is a bias-corrected version of the rst estimator.
Before applying these methods to the analysis of the causal e¤ect of SBP participation on child health,
we rst conduct a fairly extensive Monte Carlo study of the estimators considered. This is useful not only
in the present context, but also yields several recommendations for practitioners interested in applying
these methods to the evaluation of other treatments.
Our Monte Carlo results yield several striking ndings. First and foremost, researchers ought to be
skeptical of estimates obtained using methods identied from functional form assumptions unless the correct
functional form is known. Second, when the appropriate functional form is under-specied in that relevant
regressors are omitted from the model, our minimum-biased estimator improves upon the performance of
commonly used estimators that require conditional independence, as well as those relying on functional
form or heteroskedasticity for identication. Third, when the appropriate functional form is known (or is
over-specied in that irrelevant regressors are included in the model), our bias-corrected estimator does
quite well, even outperforming estimators relying purely on functional form for identication in some
situations. Finally, the Klein and Vella (2009) estimator exploiting heteroskedasticity performs very well
when the error in the treatment equation is in fact heteroskedastic, but less well if this is not the case.
The Klein and Vella (2009) estimator is also more sensitive to over-specifying the model, whereas our
bias-corrected estimator performs better when the model is over-specied.
In terms of the application, our new estimators prove to be a nice complement to existing methods
when conditional independence fails, but one lacks an exclusion restriction. Specically, we nd a positive
and statistically signicant association between SBP and child weight when using estimators that require
conditional independence. The relationship remains positive, but becomes statistically insignicant, when
we use our minimum-biased estimator. Finally, consistent with prior suggestive evidence in the literature,
we nd a negative and sometimes statistically signicant causal e¤ect of SBP participation on child weight
using the bivariate normal selection model and Klein and Vellas (2009) estimator, as well as our bias-
corrected estimator. This pattern of point estimates highlights the importance of controlling for non-
random selection in studies of the e¢ cacy of the SBP, as well as the important role the SBP plays in the
battle against childhood obesity.
The remainder of the paper is organized as follow. Section 2 provides a brief discussion of childhood
obesity in the U.S., as well as the relevant literature on school meal programs. Section 3 begins by
providing a quick overview of the potential outcomes and corresponding treatment e¤ects framework.
Next, it contains our analysis of the bias of estimators that require conditional independence. Finally,
we present our new estimation methods, as well as the discuss the existing BVN and KV estimators, in
Section 3. Section 4 presents the Monte Carlo study. Section 5 contains our analysis of the SBP. Section
2
6 concludes.
2 Background
As is quite evident from recent media reports, childhood obesity is deemed to have reached epidemic status
(Rosin 2008). Data from the National Health and Nutrition Examination Surveys (NHANES) covering
19761980 and 20032006 indicate that the prevalence of overweight preschool-aged children, aged 2-5
years, increased from 5.0% to 12.4%.2 Among school-aged children, the prevalence has risen from 6.5% to
17.0% for those aged 6-11; 5.0% to 17.6% for those aged 12-19 years.3
This rise has enormous, long-run implications given that roughly one-third of overweight preschool-aged
children and one-half of overweight school-aged children become obese adults (Serdula et al. 1993). In
turn, adult obesity is associated with numerous health and socio-economic problems (Bleich et al. 2007).
Trasande et al. (2009) estimate that childhood obesity resulted in $237.6 million in hospitalization costs
alone in 2005, up (in real terms) from $125.9 million in 2001. Finkelstein et al. (2009) estimate that the
total medical costs from obesity adults and children exceeded $100 billion in 2006 and could have been
as high as $147 billion in 2008.
Given this backdrop, policymakers in the US have acted in a number of di¤erent directions, particularly
within schools. These reforms culminated in November 2007 as the US Department of Health and Human
Services (HHS) launched the Childhood Overweight and Obesity Prevention Initiative. In addition to these
recent policy developments, two long-standing federal programs a¤ecting roughly 30 million students on a
typical school day have come under scrutiny: the SBP and the National School Lunch Program (NSLP).
The existing literature analyzing these programs  either in combination or in isolation  relies on
non-experimental data where the potential exists for non-random selection into treatment on the basis of
student-specic unobservable attributes. Three noteworthy approaches have been employed in an attempt
to circumvent this issue. First, Bhattacharya et al. (2006) employ a di¤erence-in-di¤erence (DD) strategy
and compare the weight and nutritional intake of children during the summer to that during the school
year across schools that do and do not o¤er breakfast. The authors nd evidence that children do fare
better during the school year along certain dimensions. Second, Schanzenbach (2008) utilizes a regression
discontinuity (RD) approach that exploits the sharp income cut-o¤ for eligibility for reduced-price meals
to assess the impact of the NSLP. She nds that NSLP participation increases the probability of being
obese due to the additional calories provided by school lunches. Finally, Millimet et al. (2009; hereafter
2Overweight is dened as an age- and gender-specic body mass index (BMI) greater than the 95th percentile based on
growth charts from the Center for Disease Control (CDC).
3See http://www.cdc.gov/obesity/childhood/index.html.
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MTH) apply the methodology developed in Altonji et al. (2005) to assess the sensitivity of the e¤ects of
participation in the SBP and NSLP estimated under exogeneity to deviations from this assumption. The
authors nd strong, albeit suggestive, evidence that the SBP is benecial for children, whereas the NSLP
is harmful.
Although informative, each of these approaches has limitations. The DD strategy assumes that schools
do not decide to participate in the SBP on the basis of the weight trajectories of its students, and that
children self-selecting into schools that participate in the SBP do not have di¤erent trends in weight and
nutrition relative to students attending schools not o¤ering breakfast. In addition, the treatment is school-
level breakfast availability, not student-level SBP participation. The RD approach potentially confounds
the e¤ects of participation in the SBP and NSLP since the same eligibility criteria is used for both programs.
Moreover, the RD approach estimates the local average treatment e¤ect (LATE) when the treatment e¤ect
is heterogenous.4 Finally, the Altonji et al. (2005) approach is merely suggestive, and fails to provide point
estimates of the causal e¤ects of the programs except under functional form assumptions.
In this study, we assess the causal role of the SBP in the child obesity epidemic, as well as propose
new techniques applicable more generally to the evaluation of binary treatments. We focus on the SBP
for two reasons. First, MTH and Schanzenbach (2008) both nd little evidence that NSLP participation
is non-random conditional on observables. Second, MTH nds evidence of positive selection into the SBP:
children with steeper weight trajectories over time are more likely to participate conditional on observables.
Moreover, addressing non-random selection into the SBP is vital not only for obtaining consistent estimates
of the causal e¤ect of SBP participation, but also for estimating the causal e¤ect of NSLP participation.5
MTH conclude that if there is positive selection into SBP participation on child weight, then the SBP
lowers child weight and the NSLP raises child weight once this non-random selection is addressed. Because
the underlying selection into SBP is crucial for consistently estimating the causal e¤ects of both programs,
and the analysis in MTH is only suggestive of a benecial impact of SBP participation once selection is
addressed, obtaining point estimates of the causal e¤ect of SBP participation utilizing di¤erent techniques
is of critical importance to policymakers.
4See Lee and Lemieux (2009) for a detailed discussion.
5This is true despite MTH concluding that there is no selection into NSLP on the basis of student-level unobservables.
The reason is that if SBP is erroneously treated as exogenous, then the bias due to correlation with the error term spills over
and also biases the coe¢ cient on NSLP participation since SBP and NSLP participation are highly correlated.
4
3 The Evaluation Problem
3.1 Setup
Consider a random sample of N individuals from a large population indexed by i = 1; :::; N . Utilizing
the potential outcomes framework (see, e.g., Neyman 1923; Fisher 1935; Roy 1951; Rubin 1974), let Yi(T )
denote the potential outcome of individual i under treatment T , T 2 T . Here, we consider only the case of
binary treatments: T = f0; 1g. The causal e¤ect of the treatment (T = 1) relative to the control (T = 0)
is dened as the di¤erence between the corresponding potential outcomes. Formally,
 i = Yi(1)  Yi(0):
In the evaluation literature, several population parameters are of potential interest. The most commonly
used include the ATE, the ATT, and the ATU. These are dened as
ATE = E[ i] = E[Yi(1)  Yi(0)] (1)
ATT = E[ ijT = 1] = E[Yi(1)  Yi(0)jT = 1] (2)
ATU = E[ ijT = 0] = E[Yi(1)  Yi(0)jT = 0]: (3)
In general, the parameters in (1) (3) may vary with a vector covariates, X. As a result, each of the
parameters may be dened conditional on a particular value of X as follows:
ATE [X] = E[ ijX] = E[Yi(1)  Yi(0)jX] (4)
ATT [X] = E[ ijX;T = 1] = E[Yi(1)  Yi(0)jX;T = 1] (5)
ATU [X] = E[ ijX;T = 0] = E[Yi(1)  Yi(0)jX;T = 0]: (6)
The parameters in (1) (3) are obtained by taking the expectation of the corresponding parameter in (4)
 (6) over the distribution of X in the relevant population (the unconditional distribution of X for the
ATE, and distribution of X condition on T = 1 and T = 0 for the ATT and ATU, respectively).
For each individual, we observe the triple fYi; Ti; Xig, where Yi is the observed outcome, Ti is a binary
indicator of the treatment received, and Xi is a vector of covariates. The only requirement of the covariates
included in Xi is that they are pre-determined (that is, they are una¤ected by Ti) and do not perfectly
predict treatment assignment. The relationship between the potential and observed outcomes is given by
Yi = TiYi(1) + (1  Ti)Yi(0)
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which makes clear that only one potential outcome is observed for any individual. As such, estimating 
is not trivial as there is an inherent missing data problem.
The methods utilized by researchers to circumvent this missing data problem are classied into two
groups: selection on observables estimators and selection on unobservable estimators. The distinction lies
in whether a method consistently estimates the causal e¤ect of the treatment in the presence of unobserv-
able attributes of subjects that are correlated with both treatment assignment and the outcome of interest
conditional on the set of observable variables. Assuming a lack of such unobservables is referred to as con-
ditional independence or unconfoundedness assumption (Rubin 1974; Heckman and Robb 1985). Formally,
under the conditional independence assumption (CIA), treatment assignment is said to be independent of
potential outcomes conditional on the set of covariates, X. As a result, selection into treatment is random
conditional on X and the average e¤ect of the treatment can be obtained by comparing outcomes of in-
dividuals in di¤erent treatment states with identical values of the covariates. To solve the dimensionality
problem that is likely to arise if X is a lengthy vector, Rosenbaum and Rubin (1983) propose using the
propensity score, P (Xi) = Pr(Ti = 1jXi), instead of X as the conditioning variable.
If CIA fails to hold, then consistent estimation of the causal e¤ect requires a selection on unobservables
estimation technique. The di¢ culty for applied researchers confronting such a scenario is that obtaining
a consistent point estimate of a measure of the treatment e¤ect typically requires an exclusion restriction
(i.e., an observable variable that impacts treatment assignment, but not the outcome of interest conditional
on treatment assignment).
Unfortunately, in many situations, valid exclusion restrictions, as usually conceived, are not available.
At that point, researchers have limited options: (i) abandon point estimation, instead focusing on bounding
a measure of the treatment e¤ect, (ii) rely on strong functional form assumptions for identication, or (iii)
identify the causal e¤ect from higher moments of the observed variables or heteroskedasticity. Here, we
propose two new options in addition to applying previous estimators utilizing functional form assumptions
and heteroskedasticity for identication. First, we present a minimum-biased estimator. This approach
entails the utilization of a selection on observables estimator, but restricts the estimation sample in such
a way so as to minimize the bias arising from the failure of CIA. Second, we extend our minimum-biased
estimation approach by suggesting a bias-corrected version of this estimator.
To proceed, we rst derive the bias of estimators that require CIA when, in fact, this assumption
fails under certain assumptions (namely, joint normality). We then derive our minimum-biased and bias-
corrected estimators under these same assumptions. Finally, we extend our estimators to the case where
joint normality does not hold.
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3.2 Bias When CIA Fails
Given knowledge of the propensity score, or an estimate thereof, and su¢ cient overlap between the distri-
butions of the propensity score across the T = 1 and T = 0 groups (typically referred to as the common
support condition; see Dehejia and Wahba (1999) or Smith and Todd (2005)), the parameters discussed
above can be estimated in a number of ways under CIA.6 Regardless of which such technique is employed,
each will be biased if CIA fails to hold.
Black and Smith (2004) and Heckman and Navarro-Lozano (2004) consider the bias when estimating
the ATT under CIA and the assumption is incorrect. The bias of the ATT at some value of the propensity
score, P (X), is given by
BATT [P (X)] = bATT [P (X)]  ATT [P (X)]
= fE[Y (1)jT = 1; P (X)]  E[Y (0)jT = 0; P (X)]g
 fE[Y (1)jT = 1; P (X)]  E[Y (0)jT = 1; P (X)]g
= E[Y (0)jT = 1; P (X)]  E[Y (0)jT = 0; P (X)] (7)
where bATT refers to some propensity score based estimator of the ATT requiring CIA (e.g., propensity
score matching or inverse propensity score weighting).
To better understand the behavior of the bias, Black and Smith (2004) and Heckman and Navarro-
Lozano (2004) make the following two assumptions:
(A1) Potential outcomes and latent treatment assignment are additively separable in observables and
unobservables
Y (0) = g0(X) + "0
Y (1) = g1(X) + "1
T  = h(X)  u
T =
8<: 1 if T  > 00 otherwise
6DAgostino (1998) and Imbens (2004) o¤er excellent surveys.
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(A2) "0; "1; u  N3(0;), where
 =
26664
20 01 0u
21 1u
1
37775 :
Given A1 and A2, (7) simplies to
BATT [P (X)] = E["0jT = 1; P (X)]  E["0jT = 0; P (X)]
=  0u0
(h(X))
(h(X))[1  (h(X))] (8)
where () and () are the standard normal density and cumulative density function, respectively.
As noted in Black and Smith (2004), BATT [P (X)] is minimized when h(X) = 0, which implies that
P (X) = 0:5. Thus, the authors recommend that researchers estimate ATT using the thick support
region of the propensity score (e.g., P (X) 2 (0:33; 0:67)).
Prior to continuing, it is important to note that if the ATT varies with X (and, hence, P (X)), then
using only observations on the thick support estimates a di¤erent parameter than the population ATT
given in (2). Indeed, the procedure suggested in Black and Smith (2004) accomplishes the following. It
searches over the parameters dened in (5) to nd the value of P (X) for which the ATT [P (X)] can be
estimated with the least bias. This point is very intriguing. Stated di¤erently, when unconfoundedness
fails, ATT , the population ATT, cannot be estimated in an unbiased manner using estimators that rely
on this assumption. Rather than invoking di¤erent assumptions to identify the population ATT (e.g.,
those utilized by selection on unobservables estimators), the Black and Smith (2004) approach identies
the parameter that can be estimated with the smallest bias under unconfoundedness. Whether or not the
parameter being estimated with the least bias, eATT = E[E[ ijP (X); T = 1]], where the outer expectation
is over Xj0:33 < P (X) < 0:67 and T = 1, is an interesting economic parameter is a di¤erent question. The
key point, however, is that when restricting the estimation sample to observations with propensity scores
contained in a subset of the unit interval, the parameter being estimated will di¤er from the population
ATT unless the treatment e¤ect does not vary with X (i.e., E[ ijP (X); T = 1] = E[ ijT = 1]).
With this point in mind, we now consider the bias for the ATE and the ATU since the ATT is not the
only parameter of interest in applied settings. For the ATU, it is trivial to show that
BATU [P (X)] = E["1jT = 1; P (X)]  E["1jT = 0; P (X)]
=  1u1
(h(X))
(h(X))[1  (h(X))] (9)
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which is also minimized when h(X) = 0, or P (X) = 0:5. However, it is useful to note that
BATU [P (X)] = E[ + "0jT = 1; P (X)]  E[ + "0jT = 0; P (X)]
= BATT [P (X)] + E[jT = 1; P (X)]  E[jT = 0; P (X)]
where  = "1   "0 is the unobserved, individual-specic gain from treatment. Thus, the magnitude of the
bias of the ATU may either be larger or smaller than the corresponding bias of the ATT. If we add the
following assumption:
(A3) Non-negative selection into the treatment on individual-specic, unobserved gains
E[jT = 1; P (X)] > E[jT = 0; P (X)]
then jBATU [P (X)]j > jBATT [P (X)]j for all P (X).7
Now consider the ATE. Utilizing the fact that ATE [P (X)] = P (X)ATT [P (X)]+[1 P (X)]ATU [P (X)],
and rewriting Y (1) = g1(X) + ( + "0), the bias for the ATE is given by
BATE [P (X)] =  0u0

(h(X))
(h(X))[1  (h(X))]

+ [1  P (X)]

 u
(h(X))
(h(X))[1  (h(X))]

=  f0u0 + [1  P (X)]ug

(h(X))
(h(X))[1  (h(X))]

(10)
which is equivalent to the expression derived in Heckman and Navarro-Lozano (2004).
Equation (10) leads to three salient points. First, under A1 A3, jBATU [P (X)]j > jBATE [P (X)]j >
jBATT [P (X)]j. Second, the value of P (X) that minimizes the bias of the ATE, referred to as the bias
minimizing propensity score (BMPS) and denoted P (X), is not xed; rather, it depends on the values of
0u0 and u. In particular, the bias of the ATE is minimized when h(X) = 0 only in the case where
u = 0 (i.e., no selection on unobserved, individual-specic gains to treatment). Third, there are two
special cases for which the bias disappears:
(i) No Selection on Unobservables Impacting Outcomes in the Untreated State: If 0u0 = 0, then
limP (X)!1BATE [P (X)] = 0
(ii) Equal but Opposite Selection on Unobservables: If 0u0 =  u, then limP (X)!0BATE [P (X)] = 0
Beyond these cases, P (X) displays the following properties:
7See Heckman and Vytlacil (2005) for further discussion on this assumption.
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(iii) Negative Selection: If 0u0 > 0, then P
(X) = argmin jBATE [P (X)]j is
(a) above 0.5, but monotonically increasing in u > 0
(b) above or below 0.5 for u < 0, but strictly above 0.5 for 0u0 <  0:5u (i.e., strong,
positive selection on unobserved gains)
(iv) Positive Selection: If 0u0 < 0, then P
(X) = argmin jBATE [P (X)]j is
(a) above 0.5, but monotonically decreasing in u < 0
(b) above or below 0.5 for u > 0, but strictly above 0.5 for 0u0 >  0:5u (i.e., strong,
negative selection on unobserved gain
Interestingly, when the two types of selection operate in same direction, P (X) > 0:5 implying that the
treatment e¤ect for individuals with a higher probability of receiving the treatment can be estimated with
less bias. However, when these two types of selection go in opposite direction, P (X) > 0:5 when selection
on unobserved gains is relatively large in absolute value. Thus, in this case, when there is relatively strong
selection on unobserved gains, the treatment e¤ect for individuals with a higher probability of receiving
the treatment can be estimated with less bias. Figure 1 provides a complete characterization of P (X).
4 Estimation
4.1 The Minimum-Biased Approach
In light of the preceding discussion, we propose a new estimation approach when unconfoundedness is not
likely to hold, but one lacks a valid exclusion restriction. We couch our technique within the normalized
inverse probability weighted estimator of Hirano and Imbens (2001).8 First, consider estimation of the
ATE. Horvitz and Thompson (1952) show that the ATE may be expressed as
ATE = E

Y  T
P (X)
  Y  (1  T )
1  P (X)

;
with the sample analogue given by
^HT;ATE =
1
N
NX
i=1
"
YiTi
P^ (Xi)
  Yi(1  Ti)
1  P^ (Xi)
#
: (11)
8Other propensity score estimators, such as matching, could be used as well. Millimet and Tchernis (2009) nd little
practical di¤erence between estimator of Hirano and Imbens (2001) and kernel matching.
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The estimator in (11) is the unnormalized estimator as the weights do not necessarily sum to unity. To
circumvent this issue, Hirano and Imbens (2001) propose an alternative estimator, referred to as the
normalized or HI estimator, which is given by
^HI;ATE =
"
NX
i=1
YiTi
P^ (Xi)
,
NX
i=1
Ti
P^ (Xi)
#
 
"
NX
i=1
Yi(1  Ti)
1  P^ (Xi)
,
NX
i=1
(1  Ti)
1  P^ (Xi)
#
: (12)
Millimet and Tchernis (2009) provide evidence of the superiority of the normalized estimator in practical
settings.
Under CIA, the HI estimator in (12) provides an unbiased estimate of ATE . When this assumption
fails, the bias is given (10). Rather than abandon this estimator, however, we propose to alter the estimator
in such a manner so as to minimize the bias. Specically, we suggest estimating (12) using only observations
with a propensity score in a neighborhood around the BMPS, P .9 Formally, we propose the following
minimum-biased (MB) estimator of the ATE:
^MB;ATE [P
] =
"X
i2

YiTi
P^ (Xi)
,X
i2

Ti
P^ (Xi)
#
 
"X
i2

Yi(1  Ti)
1  P^ (Xi)
,X
i2

(1  Ti)
1  P^ (Xi)
#
(13)
where

 = fijP^ (Xi) 2 C(P )g;
and C(P ) denotes a neighborhood around P . In the estimation below, we dene C(P ) as
C(P ) = fP^ (Xi)jP^ (Xi) 2 (P ; P )g;
where P = maxf0:02; P    g, P = minf0:98; P  + g, and  > 0 is the smallest value such that at
least  percent of both the treatment and control groups are contained in 
. In the exercises below, we
set  = 0:05 and 0:25. For example, if  = 0:05, 0:05 is the smallest value such that 5% of the treatment
group and 5% of the control group have a propensity score in the interval (P ; P ). Thus, smaller values of 
should reduce the bias at the expense of higher variance. Note, we trim observations with propensity scores
above (below) 0.98 (0.02), regardless of the value of , to prevent any single observations from receiving
too large of a weight.
As dened above, the set 
 is unknown since, in general, P  is unknown. To estimate the set 
,
we propose to estimate P  assuming A1, A2, and functional forms for g0(X), g1(X), and h(X) using
9For simplicity, we suppress the notation denoting the fact that the BMPS depends on X.
11
Heckmans bivariate normal (BVN) selection model. Specically, assuming
g0(X) = X0
g1(X) = X1
h(X) = X
then
yi = Xi0 +XiTi(1   0) + 0(1  Ti)

(Xi)
1  (Xi)

+ 1Ti
 (Xi)
(Xi)

+ i (14)
where ()=() is the inverse Millsratio,  is a well-behaved error term, and
0 = 0u0 (15)
1 = 0u0 + u:
Thus, OLS estimation of (14) after replacing  with an estimate obtained from a rst-stage probit model
yields consistent estimates of 0u0 and u. With these estimates, one can use (10) to obtain an estimate
of P .10
Our proposed estimator immediately raises a question: If one is willing to maintain the assumptions
underlying the BVN selection model in (14), why not just use the OLS estimates of (14) to estimate the
ATE? Well, perhaps one should. Upon estimating the BVN selection model, the ATE is given by
^BV N;ATE = X
b1   b0 : (16)
However, if the assumptions of the BVN model do not hold, or if the BVN model is poorly identied, then
perhaps the estimator in (12) or (13) will perform better in practice. Moreover, when one is interested in
the ATT rather than the ATE, our minimum biased approach can be utilized without estimation of (14)
since P  is known to be one-half. In this case, our estimator couched in the HI estimator of the ATT 
is given by
^MB;ATT [P
] =
X
i2

YiTi  
"X
i2

Yi(1  Ti)P^ (Xi)
1  P^ (Xi)
,X
i2

(1  Ti)P^ (Xi)
1  P^ (Xi)
#
: (17)
For comparison, under the functional form assumptions for g0(X), g1(X), and h(X) discussed above,
10To estimate P , we conduct a grid search over 1,000 equally-spaced values of h() from -5 to 5. If P  is above 0.98, we
truncate it to 0.98; if P  is below 0.02, we truncate it to 0.02.
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OLS estimation of (14) also produces a consistent estimate of the ATT. This estimator is given by
^BV N;ATT = X1
b1   b0+ b1 (Xib)(Xib)

1
(18)
where X1 and
h (Xib)
(Xib)
i
1
are the sample means of X and the selection correction term, respectively, in
treatment group.
4.2 The Bias-Corrected Approach
While (13) and (17) provide a minimum-biased estimator of the ATE and ATT, respectively, estimation
of the error correlation structure using (14) immediately gives rise to the possibility of a bias-corrected
version of each estimator. Specically, after estimating (14), estimates of the bias of the minimum-biased
estimator of the ATE and ATT are given by
\BATE [P ] =  

\0u0 + (1  P )\u
 ( 1(P ))
P (1  P )

and
\BATT [0:5]   1:6 \0u0:
Bias-corrected estimators, denoted MB-BC, are then given by
^MB BC;ATE [P ] = bMB;ATE [P ]  \BATE [P ] (19)
^MB BC;ATT [P ] = bMB;ATT [P ]  \BATT [P ]: (20)
4.3 Deviations from Normality
The analysis to this point has relied on the assumption of joint normality; an assumption that may be
unrealistic in many applications. As a result, before turning to our Monte Carlo study, we consider
deviations from the normality assumption. To proceed, we follow Lee (1984) who utilizes the fact that
under certain assumptions the (unknown) joint density of "j and u, fj("j ; u), j = 0; 1, may be written as
a bivariate Edgeworth series of distributions. Formally,
fj("j ; u) = 2("j ; u) +
X
r+s3
( 1)r+sArs 1
r!s!
@r+s2("j ; u)
@ur@"sj
(21)
where 2 is the bivariate standard normal density and Ars are functions of the cumulants (or semi-
invariants) of "j and u.
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As in Lee (1984), we consider the case where r+ s 2 f3; 4g, referred to as a Type AA surface in Mardia
(1970), and u  N(0; 1). In light of this, the bias of the ATT is now given by
BATT [P (X)] = E["0jT = 1; P (X)]  E["0jT = 0; P (X)]
=  
(
0u0 + 120
h(X)
2
+ 130

h(X)2   1
6
)
(h(X))
(h(X))[1  (h(X))]

(22)
where ij are semi-invariants (or cumulants). For the ATU, we have by symmetry
BATU [P (X)] = E["1jT = 1; P (X)]  E["1jT = 0; P (X)]
=  
(
1u1 + 
0
121
h(X)
2
+ 0131

h(X)2   1
6
)
(h(X))
(h(X))[1  (h(X))]

(23)
Alternatively,
BATU [P (X)] = E[ + "0jT = 1; P (X)]  E[ + "0jT = 0; P (X)]
= BATT [P (X)] + E[jT = 1; P (X)]  E[jT = 0; P (X)]
=  
8<: 0u0 + 120
h(X)
2 + 130
[h(X)2 1]
6
+ u + 
00
12
h(X)
2 + 
00
13
[h(X)2 1]
6
9=;

(h(X))
(h(X))[1  (h(X))]

For the ATE, the bias is
BATE [P (X)] =  
8><>:
0u0 + 120
h(X)
2 + 130
[h(X)2 1]
6
+ [1  P (X)]

u + 
00
12
h(X)
2 + 
00
13
[h(X)2 1]
6

9>=>;

(h(X))
(h(X))[1  (h(X))]

(24)
Minimizing the bias of the three parameters requires knowledge or estimates of several additional
parameters. However, these are estimable from an altered version of the BVN selection model:
yi = Xi0 +XiTi(1   0)
+01(1  Ti)

(Xi)
1  (Xi)

+ 02(1  Ti)

Xi
2
(Xi)
1  (Xi)

+ 03(1  Ti)

(Xi)
2   1
6
(Xi)
1  (Xi)

+11Ti
 (Xi)
(Xi)

+ 12Ti
 Xi
2
(Xi)
(Xi)

+ 13Ti

1  (Xi)2
6
(Xi)
(Xi)

+ i (25)
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where
01 = 0u0
02 = 120
03 = 130
11 = 0u0 + u
12 = 120 + 
00
12
13 = 130 + 
00
13:
Upon estimation of (25), the BMPS is found by minimizing the bias in (24). The remainder of the
estimation algorithm is unchanged.
4.4 Klein & Vella (2009) Estimator
For comparison to the previous estimators, we also employ the estimator of Klein and Vella (2009; hereafter
KV). Our parametric implementation of this estimator relies on a similar functional form assumption to
the BVN estimator in the absence of heteroskedasticity, but e¤ectively induces valid exclusion restrictions
in the presence of heteroskedasticity. To proceed, suppose that latent treatment assignment is now given
by
T  = X   u
where u = S(X)u and u is drawn from a standard normal density. In this case, the probability of receiving
the treatment conditional on X is given by
Pr(T = 1jX) = 

X
S(X)


: (26)
Assuming S(X) = exp(X), the parameters of (26) are estimable by maximum likelihood (ML), with the
log-likelihood function given by
lnL =
X
i

ln

X
exp(X)
Ti 
ln

1  

X
exp(X)
1 Ti
(27)
where the element of  corresponding to the intercept is normalized to zero for identication.
The ML estimates are then used to obtain the predicted probability of treatment, \P (X), which may
be used as an instrument for T in equation (14) excluding the selection correction terms.11 Note, even if
11 Interactions between \P (X) and X may also serve as instruments given inclusion of interactions between T and X in (14).
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S(X) = 1, \P (X) remains a valid instrument since it is non-linear in X. However, since the non-linearity
arises mostly in the tails, identication typically relies on a small fraction of the sample. On the other
hand, if S(X) 6= 1, then the KV approach e¤ectively induces a valid exclusion restriction as Z  X=S(X)
is frequently linearly independent of X (Klein and Vella 2009).
5 Monte Carlo Study
5.1 Setup
To assess the performance of the various estimators, we use two primary experimental designs. In the rst
design, the data-generating process (DGP) imposes the constant treatment e¤ect setup (i.e.,  i =  for all
i). In the second design, the DGP gives rise to heterogeneous treatment e¤ects, where the heterogeneity is
due to unobserved, individual-specic gains to treatment (i.e.,  i varies across i, but this variation arises
due to di¤erences in "1i   "0i). In this study, in part motivated by our application, we do not consider
the case where the treatment e¤ect is heterogeneous on the basis of observables; the vectors 0 and 1 are
identical except for the intercept.
We assess nite sample performance by simulating 250 data sets, each with 5,000 observations, con-
taining
x1; x2
iid U( 1; 1)
and
h(X) = 0:5(x1   x2) + 0:5(x21   x22) + 2x1x2
T  = 0:5 + h(X)  u
T =
8<: 1 if T  > 00 otherwise
where u is dened below.12
In the constant treatment e¤ect setup, there is a common e¤ect " = "0 = "1 and potential outcomes
are given by
Y (0) = g0(X) + "0 = h(X) + "
Y (1) = g1(X) + "0 = 1 + h(X) + "
12We also simulated 50 data sets with 250,000 observations each to assess large sample performance. Results are available
in Appendix B.
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which implies that  i = 1 for all i and ATE = ATT = ATU = 1. In the second design, where treatment
e¤ects are heterogeneous on the basis of unobserved gains, potential outcomes are given by
Y (0) = g0(X) + "0 = h(X) + "0
Y (1) = g1(X) + "1 = 1 + h(X) + "1
which implies that  i = 1 + "1i   "0i = 1 + i and ATE = 1 + E[i], ATT = 1 + E[ijTi = 1], and
ATU = 1 + E[ijTi = 0].
Within each of the two experimental designs, we consider four general error structures. In the rst
structure, the errors are multivariate normal
"0; "1; u  N3(0;)
where
 =
26664
1 01 0u
1 1u
1
37775 :
and 01 = 1 in the common e¤ect setup, implying u = 0 and 0u = 1u. In the heterogeneous e¤ect
setup, 01 = 0:5 implying u = 1u   0u. In the second error structure, the errors are drawn from an
asymmetric and non-normal multivariate distribution with the desired correlation matrix using the method
in Headrick and Sawilowsky (1999). Specically, "0 and "1 are mean zero with unit variance and skewness
and kurtosis close to a 21 distribution (skewness is roughly
p
8 and kurtosis is around 15); u continues to
have a standard normal distribution. The third and fourth error structures are identical to the preceding
cases except we introduce heteroskedasticity in the treatment assignment equation. Specically, we dene
u = (1 + 0:45(x1 + x2))u and T  = 0:5 + h(X)  u.
In the constant treatment e¤ect experimental design, we consider three cases: 0u equal to zero, -0.25,
and -0.50, where CIA holds in the rst case and larger values of 0u (in absolute value) correspond to greater
selection on unobservables.13 In the heterogeneous treatment e¤ect experimental design, we consider three
cases: 0u = u = 0, 0u =  0:20 and u =  0:10, and 0u =  0:40 and u =  0:10, where CIA
again holds in the rst case and larger values of 0u (in absolute value) correspond to greater selection on
unobservables.
Finally, for each DGP considered, we use four specications when implementing the various estimators.
13Given the DGP for T , 0u < 0 indicates positive selection (i.e., unobservables associated with better outcomes are also
associated with a higher probability of receiving the treatment).
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The specications di¤er in terms of the functional form of the treatment assignment model, as well as the
outcome equations in (14) and (25). Specication (1) includes only linear terms for x1 and x2 (hence, x21, x
2
2,
and x1x2 are omitted) in the probit model for treatment assignment and in (14) and (25). Specication (2)
includes x1, x2, x21, x
2
2, and x1x2 in the set of covariates used in the probit model for treatment assignment
and in (14) and (25). Specication (3) is identical to Specication (2) but adds cubic terms for x1 and x2
as well as the complete set of interaction terms between the linear and quadratic terms. Specication (4) is
identical to Specication (3) but incorporates an additional, completely irrelevant regressor, x3  U( 1; 1),
and includes x3, x23, x
3
3, and the full set of interaction terms in the set of covariates. In Specications (1)
(3), we model S(X) = S(x1; x2); in specication (4), we model S(X) = S(x1; x2; x3).
Two nal comments are warranted. First, we assume in all cases that the researcher knows that the
treatment e¤ect does not vary on the basis of observables. As such, we exclude interactions between T and
the set of covariates in X in (14) and (25). Second, Specication (1) is under-specied, Specication (2) is
the correct specication, and Specications (3) and (4) are over-specied. Examination of these di¤erent
cases is motivated by the fact that the applied researcher likely does not know the correct functional
form even if the researcher knows the set of covariates in the model. In addition, Millimet and Tchernis
(2009) nd that over-specifying the propensity score model when unconfoundedness holds is warranted.
We explore whether this conclusion extends to the current situation.
5.2 Results
5.2.1 Correct Specication
Results for the ATE and ATT from the rst experimental design constant treatment e¤ect using the
correct specication, Specication (2), are presented in Table 1. Figures represent Root Mean Squared
Errors (RMSE). Panel I displays the results when the errors are normal; Panel II displays the results when
the errors are asymmetric and non-normal. The left (right) set of columns corresponds to the case where
the error in the treatment assignment is homoskedastic (heteroskedastic). Within each column, the shaded
number represents the smallest RMSE.
Columns (1) and (4) correspond to the simplest case: the treatment e¤ect is constant and conditional
independence holds. Three ndings emerge. First, consonant with our expectations, the HI estimator
performs best for the ATE with or without homoskedastic errors (Column (1)). However, our MB estimator
with a large radius ( = 0:25) fares only marginally worse than HI. Second, the HI estimator and MB
estimator with a large radius ( = 0:25) achieve almost identical performance for the ATT when errors are
homoskedastic; our MB estimator with a large radius ( = 0:25) performs marginally worse than HI with
18
heteroskedastic errors (Column (4)). Third, even when normality holds, KV, BVN, and MB-BC have a
higher RMSE than HI and MB for both the ATE and ATT. This is not surprising given the e¢ ciency loss
from not utilizing conditional independence when this holds in the DGP. Finally, BVN, MB, and MB-BC
outperform their counterparts allowing for non-normality even when the errors are non-normal. Thus, the
exibility o¤ered by these estimators is more than o¤set by the imprecision resulting from the increased
parameterization of the model.
Columns (2), (3), (5), and (6) introduce selection on unobservables into the DGP, with (3) and (6)
containing the largest amount of selection on unobservables. For the ATE (Columns (2) and (3)), three
salient conclusions emerge. First, with relatively modest selection on unobservables (Column (2)), KV,
BVN, and MB-BC with a large radius ( = 0:25) perform comparably, with KV doing marginally worse
than the other two estimators when errors are homoskedastic. Second, with relatively strong selection
on unobservables (Column (3)), KV performs slightly better than BVN and MB-BC with a large radius
( = 0:25) except in the case of normal and homoskedastic errors where BVN and MB-BC have lower
RMSEs. Finally, as in the case of selection on observables, BVN and MB-BC outperform their counterparts
allowing for non-normality even when the errors are non-normal.
When there is selection on unobservables and one is interested in the ATT (Columns (5) and (6)), the
conclusions are only slightly altered. First, with relatively modest selection on unobservables (Column
(5)), KV, BVN, and MB-BC with a large radius ( = 0:25) continue to have similar RMSEs with BVN
doing marginally better than the other two estimators except in the case of non-normal and heteroskedastic
errors. Second, with relatively strong selection on unobservables (Column (6)), KV, BVN, and MB-BC
with a large radius ( = 0:25) perform comparably when errors are normal; KV performs signicantly
better than the other two estimators when errors are non-normal. This result holds regardless of whether
the errors are homoskedastic or not. Finally, as in the prior cases, BVN and MB-BC outperform their
counterparts allowing for non-normality even when normality does not hold.
Next, we turn to the results for the ATE and ATT from the second experimental design. Recall, with
this DGP, the treatment e¤ect varies across observations due to individual-specic, unobserved gains to
treatment. Results obtained using the correct specication, Specication (2), are presented in Table 2.
Columns (1) and (4) again correspond to the case of selection on observables. The qualitative ndings
are unchanged from the corresponding columns in Table 1. Specically, HI continues to perform best for
both ATE and ATT, but MB with a large radius ( = 0:25) has only a marginally higher RMSE. Similarly,
the majority of the ndings from Table 1 continue to hold when focusing on the ATE and ATT under
selection on unobservables (Columns (2), (3), (5), and (6)). The only noteworthy change is that now BVN
outperforms KV in the case of non-normal and homoskedastic errors with relatively strong selection on
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unobservables for the ATE (Column (3)).14
Taking a step back, three conclusions emerge that should be of interest to applied researchers. First,
under selection on observables, HI is preferred, but MB with a large radius is very comparable even in small
samples. Moreover, MB is more robust to selection on unobservables than HI when the focus is on the ATE.
Thus, MB provides researchers with an alternative estimator that can serve as a useful robustness check to
the usual HI estimator when the selection on observables assumption is questionable, but the parameter
of interest is the ATE. Second, if the researcher is condent there is selection on unobservables, then
KV, BVN, and MB-BC with a large radius are the preferred estimators. In particular, BVN is preferred
when errors are homoskedastic, unless the focus is on the ATT and there is relatively strong selection on
unobservables in which case MB-BC is preferred. KV is preferred when errors are heteroskedastic. As
stated earlier, since the MB and MB-BC estimators rely on the BVN estimator, it might seem odd not to
simply use the BVN estimator. However, as the simulations indicate, there are multiple scenarios in which
the MB or MB-BC estimator outperform the BVN (and KV) estimators. Finally, there is little gain in
general from the estimators based on deviations from normality. This arises due to the noise introduced
through the estimation of additional parameters in (25).
5.2.2 Under- and Over-specifying the Model
The preceding results assume that the proper specication for the observables is known. Since this is rarely
true in practice, we now assess the performance of the estimators considered herein when this assumption
is relaxed. The results are relegated to Appendix A.
Tables A1A3 correspond to the rst experimental design where the treatment e¤ect is constant across
all observations. Table A1 corresponds to the case of selection on observables, A2 to the case of moderate
selection on unobservables, and A3 to the case of strong selection on unobservables. Within each table,
Columns (1) through (4) correspond to Specications (1)  (4) dened previously; thus, Column (1)
is under-specied, Column (2) is correctly specied and simply repeats the results from Table 1, and
Columns (3) and (4) are over-specied. Tables A4A6 are similarly organized, but correspond to the
second experimental design where the treatment is heterogeneous due to individual-specic, unobserved
gains to treatment.
To begin, consider the case of selection on observables when the focus is on the ATE (Table A1 and
A4). Four interesting conclusions can be drawn. First, HI continues have the smallest RMSE when the
14There are also two instances where MB (Table 2, Panel II, Column (3) with heteroskedastic errors) and MB-EE (Table
2, Panel II, Column (5) with homoskedastic errors) perform best. We do not pay much attention to these cases as these
estimators do not signicantly outperform the other estimators in these specications, while they perform particularly poorly
in other specications. Thus, a researcher would be hard-pressed to justify use of these estimators when the exact DGP is
unknown.
20
model is over-tted. In addition, as demonstrated in Millimet and Tchernis (2009), there is no penalty to
over-tting, and in many cases the RMSE actually falls. This is also consistent with Hirano et al. (2003)
who nd that using an estimated propensity score is preferable even when the true propensity score is
known, as well as recent work in Abadie and Imbens (2009) who nd that the asymptotic variance of
propensity score matching estimators is smaller when the propensity score is estimated (as opposed to
known).
Second, as found in Tables 1 and 2 using the correct specication, MB with a large radius ( = 0:25) is
very comparable in performance to HI and, as with HI, over-tting improves its performance. Third, if the
model is under-specied, MB-EE with a small radius ( = 0:05) does best when the errors are homoskedas-
tic, whereas MB with a small radius ( = 0:05) does best when the errors are heteroskedastic. Thus, when
the researcher believes that conditional independence holds, but is unsure of the proper functional form,
MB with a small radius provides a viable sensitivity check as it performs signicantly better than HI and
MB-EE when errors are heteroskedastic, and only marginally worse than MB-EE (but still much better
than HI) when errors are homoskedastic.
Finally, when the model is under-specied (Column (1)), which induces selection on unobservables, KV,
BVN, BVN-EE, MB-BC, and MB-BC-EE perform very poorly despite their design to circumvent selection
on unobservables. In fact, the RMSE for KV is roughly eight times larger than MB and MB-EE, while
the RMSE for BVN and MB-BC (BVN-EE and MB-BC-EE) is at least 30 (550) times larger. Thus, when
applying these estimators, researchers must be very wary of under-specifying the model.
When selection is still only on observables but one focuses on the ATT, the conclusions drawn change
somewhat. Specically, HI continues to do best when the model is over-tted, with MB with a large
radius ( = 0:25) performing only marginally worse, and over-tting beneting the performance of both
estimators. In addition, KV, BVN, BVN-EE, MB-BC, and MB-BC-EE continue to perform very poorly
when the model is under-specied. However, if the model is under-specied, now MB with a small radius
( = 0:05) does best when the errors are homoskedastic, whereas MB-EE with a small radius ( = 0:05)
does best when the errors are heteroskedastic. Moreover, when the errors are heteroskedastic and the
model is under-tted, MB has a higher RMSE than HI. Consequently, when the researcher is focusing on
the ATT and believes that conditional independence holds, but is unsure of the proper functional form,
MB-EE with a small radius is recommended as a sensitivity check as it performs signicantly better than
HI and MB when errors are heteroskedastic, and only marginally worse than MB (but still much better
than HI) when errors are homoskedastic.
Finally, consider the case of selection on unobservables (Tables A2, A3, A5, and A6). Upon digesting
the results, two salient patterns emerge. First, as in Tables A1 and A4, when under-tting the model,
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MB and MB-EE with a small radius ( = 0:05) perform much better than the remaining estimators in
most cases, with MB doing marginally better for the ATE under heteroskedasticity and the ATT under
homoskedasticity. Second, when using the correct specication or when over-tting, KV, BVN, and MB-BC
with a large radius ( = 0:25) are comparable overall and generally outperform the remaining estimators.
However, the relative ranking among these three varies depending on the parameter of interest, whether
the errors are normal and/or homoskedastic, and whether the model is correctly specied or over-specied.
For example, with normal errors (Panel I in each of the tables), BVN and MB-BC have similar RMSEs
and outperform KV although the margin is narrower (or eliminated) when the model is correctly specied
and the errors are heteroskedastic; unlike most of the other estimators, the performance of KV is harmed
by over-tting. This same pattern tends to hold with non-normal errors in Tables A2 and A5 (modest
selection on unobservables). However, in Panel II of Table A3 (constant treatment e¤ect with non-normal
errors), KV tends to do very well, particularly when the errors are heteroskedastic or the focus is on
the ATT. Thus, with relatively strong selection on unobservables and non-normal errors, KV is superior.
In contrast, in Panel II of Table A6 (heterogeneous treatment e¤ect with non-normal errors), BVN does
quite well when the focus is on the ATE (with MB-BC with a large radius ( = 0:25) performing only
marginally worse) or the ATT with homoskedastic errors, whereas KV does best when estimating the ATT
with heteroskedastic errors.
5.2.3 Discussion
In light of the Monte Carlo results, the applied researcher is presented with a new set of tools that should
prove useful in assessing the causal impact of a treatment. If one believes that individuals select into the
treatment on the basis of observables only, but the proper functional form is unknown, then it is best
to use HI and denitely err on the side of over-tting the propensity score model. Moreover, our MB or
MB-EE estimator with a large radius provides a useful robustness check to HI as it performs nearly as
well when the model is correctly specied or over-specied, and better when the propensity score model is
under-specifed.
If one believes that individuals select into the treatment on the basis of unobservables, but the proper
functional form is unknown, then KV, BVN, and MB-BC perform well in general, with KV performing
marginally better (worse) when the error in the treatment equation is heteroskedastic (homoskedastic).
In addition, despite the heavy reliance of the MB-BC estimator on the BVN selection model, there are
multiple instances where MB-BC has a lower RMSE than BVN. Finally, it is again best to err on the
side of over-tting the model, and there is no advantage gained by using the BVN or MB-BC estimators
allowing for non-normality.
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6 Application
6.1 Background
As recognition of the importance of breakfast to overall health, as well as academic achievement, has grown,
so to has the popularity and scrutiny of the SBP. The SBP is a federally funded program, overseen by
the US Department of Agriculture (USDA), but administered by state education agencies. The SBP was
established in 1966 by the Child Nutrition Act, and made permanent in 1975. Participation by schools
 both public and private  is voluntary (unless mandated by the state). In 1970, roughly 0.5 million
students were served on an average school day. This gure increased to 4.0 million in 1990, 7.5 million in
2000, and 10.5 million in 2008 (8.1 million of which were free or reduced-price meals).15 The program cost
the federal government $2.4 billion in 2008.
If schools do participate, they are reimbursed a xed amount per breakfast served.16 However, to
qualify for reimbursement, the meals must meet federal nutrition guidelines established in 1995 under the
School Meals Initiative for Healthy Children (SMI). This entails no more than 30% of the breakfasts
calories be derived from fat, and less than 10% from saturated fat. Breakfasts also must provide one-fourth
of the Recommended Dietary Allowance for protein, calcium, iron, Vitamin A, Vitamin C, and contain an
age-appropriate level of calories.
Enforcement of the SMI requirements is handled by requiring states to monitor local school food
authorities through reviews conducted at least once every ve years. In turn, the USDA monitors state
compliance with this review requirement. The USDA has also begun to provide regional and local training
to ensure adequate overview, as well as training in the preparation of healthy meals and dissemination of
information for children related to the importance of a healthy diet.
6.2 Data
To analyze the impact of SBP participation on child health, we utilize data from the Early Childhood
Longitudinal Study-Kindergarten Class of 1998-99 (ECLS-K). We measure participation in the SBP in
spring rst grade; we ignore kindergarten participation due to many children attending half-day programs.
Our outcomes of interest are measures of child health in spring third and fth grade or the change from
fall rst grade to spring third and fth grade. As such, we are analyzing more of the long-run relationship
15Students residing in households with family incomes at or below 130% of the federal poverty line are eligible for free meals,
while those in households with family incomes between 130% and 185% of the federal poverty line are entitled to reduced price
meals. In addition, children from households that receive aid through food stamps, Temporary Assistance for Needy Families,
or the Food Distribution Program on Indian Reservations are automatically eligible for free meals.
16For the 2009-2010 school year, reimbursement rates are $1.46 per free meal, $1.16 per reduced-price breakfast, and $0.26
per full-priced breakfast. Schools establish their own prices for full price meals, but prices for reduced price meals are capped.
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between child health and SBP participation. We utilize three measures of child health:
(i) growth rate in BMI (i.e., change in log BMI) from rst grade to spring third and fth grade,
(ii) indicator for overweight status in spring third and fth grade, and
(iii) indicator for obesity status in spring third and fth grade,
where we dene overweight (obesity) as having a BMI above the (85th) 95th percentile.17
The following covariates are included in X: childs race (white, black, Hispanic, and other), age, and
gender, childs birth weight, household socioeconomic (SES) status, mothers employment status, mothers
education, number of childrens books at home, mothers age at rst birth, an indicator if the childs mother
received WIC benets prior to kindergarten, region, city type (urban, suburban, or rural), a measure of
food security, and whether the child eats a school-provided lunch.
Children with missing data for gender and age are dropped from our sample. We also restrict the
sample to public schools. Missing values for the remaining control variables are imputed and imputation
dummies are added to the control set. In addition, we restrict attention to public schools. The nal sample
contains 9,952 students when analyzing third grade outcomes, of which 3,071 participate in the SBP. The
sample size falls to 7,824 when we analyze fth grade outcomes. Table 3 provides summary statistics.
In light of the Monte Carlo results, we start with a linear model and then gradually add higher order
and interaction terms for the continuous covariates as a specication check. In addition, in the interest
of brevity, we do not present any of the estimators based on non-normality given their poor performance;
even if the model is under-specied, MB is preferred to MB-EE when the errors are heteroskedastic (as
they are in this case) and the focus is on the ATE.18
6.3 Results
6.3.1 Baseline Specications
The results are presented in Tables 46, where Table 4 contains the results using BMI growth to measure
child health and Table 5 (Table 6) displays the results using overweight (obesity) status as the outcome.
Panel A in each table displays the estimates of the ATE, while Panel B presents the ATT estimates. As
stated above, we present the results from three specications: Specication (1) includes only linear terms
in X; Specication (2) adds squared and interaction terms for the continuous covariates; Specication (3)
17Percentiles are obtained using the -zanthro- command in Stata.
18While we present results for both the ATE and ATT, the ATE is of more relevance to policymakers interested in expanding
participation in the SBP to reach new students in order to potentially combat the rise in childhood obesity.
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includes cubic terms for the continuous covariates and interaction terms among the linear and squared terms
involving the continuous covariates. Finally, 90% condence intervals for all the estimates are obtained by
bootstrap with 250 repetitions.19
Turning to the results in Table 4, OLS and HI indicate a positive and statistically signicant association
between SBP and BMI growth regardless of whether one measures growth between rst and third grade
or rst and fth grade, regardless of whether one focuses on the ATE or ATT, and regardless of model
specication. In terms of magnitudes, the results indicate that SBP participation in rst grade is associated
with roughly a 1% (2.5%) increase in BMI growth for the average student between rst and third (fth)
grade according to HI.
If we consider the model to be under-specied, then the MB estimates with a small radius ( = 0:05) are
preferred and fail to nd a statistically meaningful relationship between SBP and BMI growth. Notably,
while this arises in part due to a loss in precision, it also reects in part a reduction in the point estimates.
Relative to the ATE, the point estimates fall in magnitude between eight and 72 percent. Relative to
ATT, the point estimates fall between 75 and 111 percent using the third grade outcome, while they
remain virtually constant using the fth grade outcome.
When we move on to the estimators designed to circumvent selection on unobservables, the point
estimates become negative regardless of outcome, parameter of interest, or specication. Erring on the
side of over-specifying the model, the KV, BVN, and MB-BC estimators each roughly indicate a 1%
decrease in BMI growth for the average student between rst and third grade according to Specication
(3).20 In addition, the estimates are statistically signicant in all cases except for KV. For the fth grade
outcome, the estimates range from a 2.1% (KV) to 4.4% (BVN) decline in BMI growth for the average
student, although none are statistically signicant. In terms of the ATT estimates, the point estimates
range from 1.2% to 3.7% depending on the estimator and the outcome. Again, none of the estimates are
statistically signicant.
In sum, the results in Table 4 indicate the importance of addressing positive selection into SBP on the
basis of weight trajectories in order to estimate the causal e¤ect of participation, as suggested in MTH.
Moreover, consistent with this view, the MB estimator is able to reduce the selection bias su¢ ciently
such that the positive and statistically signicant e¤ect obtained by estimators that require conditional
independence disappears. Finally, the KV, BVN, and MB-BC estimators each appear able to circumvent
this non-random selection and indicate, at worst, no impact of SBP on child weight and, at best, a small,
19Note, when obtaining condence intervals for MB and MB-BC, we re-estimate \P (X) within each bootstrap repetition.
20For the KV estimator, we note that for all models estimated in this study, we reject the null of homoskedastic errors at
the p < 0:01 condence level. In addition, the F-statistic on the instrument in the rst-stage is always well in excess of Stock
et al.s (2002) rule-of-thumb value of ten. Detailed results are available from the authors upon request.
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benecial causal e¤ect of participation.
Tables 5 and 6 present the results using overweight and obesity status as the outcome of interest. Qual-
itatively, the pattern of results across estimators, specications, and parameters of interest are unchanged
from Table 4. The magnitudes, however, do suggest an economically more meaningful impact of SBP
participation. Specically, according to the preferred Specication (3), the HI estimates indicate that SBP
participation is associated with a 4.8% (3.4%) increase in the probability of being overweight in the third
grade for the average student (average student in the treatment group); a 2.8% (3.2%) increase in the
probability of being obese in the third grade for the average student (average student in the treatment
group). The point estimates are even larger when we measuring child status in fth grade. However, the
corresponding estimates KV, BVN, and MB-BC estimates suggest a 8.8 to 23.0% decline in the probability
of being overweight in the third grade depending on which estimator one uses and whether one focuses on
the ATE or ATT; 10.8 to 27.8% when using fth grade overweight status. Similarly, the three estimators
indicate a 7.6 to 18.2% decline in the probability of being obese in the third grade; 4.3 to 13.4% when using
fth grade obesity status. As in Table 4, the KV estimates are never statistically signicant; the BVN and
MB-BC estimates are in some instances.
The combined results do paint a picture consistent with the results in MTH. Specically, without
controlling for any selection on unobservables, SBP appears to be a contributing factor to the childhood
obesity crisis. However, after controlling for some of this selection by minimizing the bias, the results are
weakened somewhat. Finally, when we remove the bias entirely using the KV, BVN, or MB-BC estimator,
there is no longer any evidence that SBP contributes to childhood obesity, and in fact there is some
statistically meaningful evidence to the contrary.
6.3.2 Further Investigations
Before concluding, we extend our analysis in two directions. The rst direction relates to the presence of
underweight children. When conceived, the original focus of the SBP (and the NSLP) was on providing all
children with a minimum level of nutrition (Guthrie et al. 2009). Only recently, with the rise in childhood
obesity, has concern shifted to the upper end of the weight distribution, with these programs trying to help
children maintain a healthy weight (as opposed to being overweight). However, it is important to examine
if the SBP has lost site of its original mission in bringing underweight children into a healthy weight range.
To that end, we create a binary indicator for underweight status, dened as one if children have a BMI
below the 20th percentile.21 In light of the positive selection into the SBP on the basis of weight discussed
21The CDC denes underweight as being below the fth percentile. However, there are very few children below the fth
percentile in the data; thus, we use a higher cut-o¤. In terms of trends, using the o¢ cial CDC denition of underweight,
the incidence of underweight children between the ages of six and eleven has declined from 5.3% in 19711974 to 2.7% in
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previously, now we expect the selection on observables estimators to be biased downward.
The results are presented in Table 7. Consistent with our expectations, OLS and HI indicate a negative
association between SBP and the probability of being underweight regardless of whether one measures
weight in third or fth grade, regardless of whether one focuses on the ATE or ATT, and regardless
of model specication. In nearly all cases, the estimate is statistically signicant as well. In terms of
magnitudes, the results indicate that SBP participation in rst grade is associated with roughly a 2.5%
decrease in the probability of being underweight in both third and fth grade for the average student
according to HI.
If we consider the model to be under-specied, then the MB estimates with a small radius ( = 0:05)
are preferred and fail to nd a statistically meaningful relationship between SBP and being underweight.
This arises, by and large, from a decline in precision although the point estimates for the ATE do become
positive in Specications (1) and (2) for fth grade. Finally, when we turn to the estimators designed
to circumvent selection on unobservables, the point estimates are either negative and very close to zero
or become positive. While this is consistent the positive selection discussed in Tables 46, none of the
estimates are statistically signicant. Interpreting these statistically insignicant estimates as evidence of
no causal e¤ect of SBP participation on the probability of being underweight, in combination with our
prior ndings in Tables 46, indicates that SBP combats childhood obesity without sacricing its original
goal of ensuring children are not malnourished.
Our nal investigation relates to the possibility of measurement error in reported program participation.
To mitigate the possibility of mis-measurement, we follow a strategy loosely based on Black et al. (2000)
who note that one can reduce the bias from measurement error in a binary regressor if one has two mis-
measured indicators and the measurement errors are independent. In such a case, an improved estimate is
obtained by dening a binary variable equal to one if both mis-measured indicators are equal to one. To
that end, we re-estimate the models in Tables 47 except now we dene the treatment as one if the student
reported eating breakfast at school in rst and third grade (when using third grade outcomes) and rst,
third, and fth grade (when using fth grade outcomes).22
In the interest of brevity, the results are relegated to Appendix C and we simply note that the results
are qualitatively unchanged. The two most noteworthy di¤erences are the fact that the KV estimates
are now statistically signicant in many instances, and the fact that the estimated e¤ects on fth grade
outcomes are statistically signicant more often. This latter result presumably is due more to the new
20032006 (http://www.cdc.gov/nchs/data/hestat/underweight_children.pdf).
22This exercise is merely meant to be suggestive. First, the assumption that measurement error in participation reports
across waves are independent is open for debate. Second, unlike Black et al. (2000), our multiple indicators come from di¤erent
points in time. As such, if there is no measurement error in the data, we are implicitly re-dening the treatment relative to
the treatment analyzed in Tables 47.
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denition of the treatment rather than a correction for measurement error.
7 Conclusion
The program evaluation literature has expanded rapidly over the past decade. While our knowledge
concerning methods that are designed to provide consistent estimates of some measure of the causal e¤ect
of a binary treatment under conditional independence, as well as typical IV methods when conditional
independence fails, is relatively well developed, researchers are less informed about how to proceed when
conditional independence fails yet the usual type of exclusion restrictions is unavailable. In this study,
we aim to reduce this decit by proposing two new estimators for this situation, and then evaluating the
performance of our estimators as well as that of bivariate normal selection model, the selection model
extended to the case of non-normality, and a recently proposed IV estimator proposed in Klein and Vella
(2009) that relies on heteroskedasticity. In addition, we use these estimators to assess the causal impact
of a program of great interest to policymakers: the School Breakfast Program.
Our analysis leads to some general guidelines that applied researchers may wish to follow in similar
situations moving forward. First, in applications where the researcher believes conditional independence
holds, our minimum-biased estimator o¤ers a nice robustness check since it performs nearly as well when
the model is correctly specied or over-specied, but vastly better when the model is under-specied.
Second, when conditional independence does not hold but the model is correctly specied or over-specied,
our bias-corrected estimator does quite well, even outperforming estimators relying purely on functional
form for identication. Third, our parametric Klein and Vella (2009) estimator performs very well when
the error in the treatment equation is in fact heteroskedastic, but still does well when this is not the case.
Finally, consistent with Millimet and Tchernis (2009), in all cases the penalty to over-specifying the model,
if there is one at all, pales in comparison to the penalty from under-specifying the model. However, the
KV estimator appears to be most sensitive to over-tting.
In terms of our analysis of the SBP, the various estimators o¤er a coherent picture of the causal e¤ect of
the program. Specically, we nd a positive and statistically signicant association between SBP and child
weight when using estimators that require conditional independence. The association remains positive,
but becomes statistically insignicant, when we use our minimum-biased estimator. Finally, consistent
with the suggestive evidence in MTH, as well as Bhattacharya et al. (2006), we nd a negative and
mostly statistically signicant causal e¤ect of SBP participation on child weight using the bivariate normal
selection model and Klein and Vellas (2009) estimator, as well as our bias-corrected estimator.
While promising, further analysis on the econometric side may prove fruitful by considering the choice
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of  or di¤erential weighting of observations within the neighborhood around P . In addition, one may wish
to consider a bias-corrected estimator of the unconditional average treatment e¤ect when the treatment
e¤ect is heterogeneous. For instance, one might wish to obtain a bias-corrected estimate conditional on
the propensity score, P (X), and then estimate the unconditional average treatment e¤ect by taking the
expectation of this over the distribution of X in the population (or sub-population of treated). Finally,
future work may compare the estimators considered here to other estimators that circumvent the need for
an exclusion restriction; for instance, those considered in Ebbes et al. (2009) for continuous endogenous
regressors. In terms of the analysis of the SBP, future analysis into the impact of participation on other
outcomes, such as cognitive and non-cognitive skills, will provide policymakers with better information
about the potential benets of the program.
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 Figure 1. Bias-Minimizing Value of the Propensity Score Under Different Parameter 
Values. 
Note: Pכ denotes the bias-minimizing value of the propensity score. 
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Table 1.  Monte Carlo Results: Estimates in the Common Effect Model (τi = 1)
ρ0σ0 = 0 ρ0σ0 = -0.25 ρ0σ0 = -0.50 ρ0σ0 = 0 ρ0σ0 = -0.25 ρ0σ0 = -0.50 ρ0σ0 = 0 ρ0σ0 = -0.25 ρ0σ0 = -0.50 ρ0σ0 = 0 ρ0σ0 = -0.25 ρ0σ0 = -0.50
ρ01 = 1 ρ01 = 1 ρ01 = 1 ρ01 = 1 ρ01 = 1 ρ01 = 1 ρ01 = 1 ρ01 = 1 ρ01 = 1 ρ01 = 1 ρ01 = 1 ρ01 = 1
(1) (2) (3) (4) (5) (6) (1) (2) (3) (4) (5) (6)
I.  Normally Distributed Errors
  τHI 0.047 0.440 0.883 0.053 0.443 0.893 0.047 0.415 0.841 0.048 0.421 0.844
  τMB,0.05 0.113 0.407 0.795 0.102 0.411 0.800 0.138 0.406 0.817 0.114 0.432 0.817
  τMB,0.25 0.064 0.402 0.805 0.056 0.404 0.809 0.060 0.410 0.823 0.060 0.428 0.831
  τMB,EE,0.05 0.129 0.471 0.892 0.123 0.464 0.898 0.176 0.388 0.788 0.169 0.420 0.819
  τMB,EE,0.25 0.068 0.437 0.860 0.067 0.437 0.864 0.071 0.411 0.829 0.070 0.421 0.836
  τKV 0.360 0.374 0.368 0.360 0.374 0.368 0.238 0.279 0.269 0.238 0.279 0.269
  τBVN 0.301 0.287 0.278 0.226 0.245 0.312 0.232 0.265 0.300 0.177 0.259 0.394
  τMB-BC,0.05 0.312 0.301 0.287 0.321 0.296 0.294 0.257 0.266 0.317 0.259 0.294 0.334
  τMB-BC,0.25 0.296 0.291 0.285 0.307 0.283 0.277 0.225 0.264 0.314 0.240 0.278 0.328
  τBVN, EE 1.610 1.363 1.402 1.068 0.933 0.964 0.828 0.903 0.835 0.548 0.617 0.585
  τMB-BC,EE,0.05 1.319 1.268 1.422 1.381 1.185 1.247 0.730 0.823 0.791 0.688 0.761 0.731
  τMB-BC,EE,0.25 1.289 1.244 1.396 1.348 1.171 1.223 0.698 0.803 0.781 0.673 0.746 0.733
II.  Asymmetric, Non-Normally Distributed Errors
  τHI 0.050 0.378 0.628 0.055 0.348 0.489 0.048 0.364 0.641 0.051 0.339 0.511
  τMB,0.05 0.097 0.350 0.391 0.100 0.420 0.784 0.125 0.338 0.348 0.112 0.439 0.806
  τMB,0.25 0.059 0.348 0.449 0.055 0.387 0.715 0.064 0.346 0.446 0.059 0.409 0.731
  τMB,EE,0.05 0.130 0.434 0.792 0.128 0.348 0.518 0.171 0.344 0.616 0.161 0.325 0.487
  τMB,EE,0.25 0.069 0.385 0.648 0.069 0.338 0.496 0.069 0.354 0.571 0.067 0.329 0.492
  τKV 0.363 0.400 0.368 0.363 0.400 0.368 0.248 0.275 0.257 0.248 0.275 0.257
  τBVN 0.281 0.308 0.380 0.207 0.300 0.585 0.245 0.288 0.364 0.184 0.300 0.572
  τMB-BC,0.05 0.286 0.313 0.378 0.289 0.381 0.868 0.273 0.294 0.373 0.257 0.395 0.866
  τMB-BC,0.25 0.277 0.303 0.396 0.278 0.350 0.801 0.242 0.285 0.390 0.248 0.363 0.794
  τBVN, EE 1.608 1.631 1.819 1.071 1.083 1.172 0.899 0.900 1.080 0.598 0.590 0.700
  τMB-BC,EE,0.05 1.329 1.514 1.764 1.401 1.389 1.514 0.838 0.903 1.169 0.787 0.774 0.956
  τMB-BC,EE,0.25 1.296 1.503 1.786 1.377 1.374 1.443 0.815 0.872 1.125 0.762 0.749 0.874
Notes: Numbers reflect the root mean squared error based on 250 simulated data sets with 5,000 observations.  HI = Hirano and Imbens (2001) estimator; MB = minimum-biased estimator using a cut-off level (α) 
chosen to retain 5% or 25% of the treatment and control groups; KV = Klein and Vella (2009) estimator; BVN = Heckman bivariate normal selection model; MB-BC = bias corrected estimator using a cut-off level 
(α) chosen to retain 5% or 25% of the treatment and control groups.  EE implies estimator relies on the Edgeworth expansion formula.  Shading indicates best performance within each column.  See text for further 
details. 
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Table 2.  Monte Carlo Results: Heterogeneous Effect Model (τi = 1 + δ i)
ρ0σ0 = 0 ρ0σ0 = -0.20 ρ0σ0 = -0.40 ρ0σ0 = 0 ρ0σ0 = -0.20 ρ0σ0 = -0.40 ρ0σ0 = 0 ρ0σ0 = -0.20 ρ0σ0 = -0.40 ρ0σ0 = 0 ρ0σ0 = -0.20 ρ0σ0 = -0.40
ρ01 = 0.50 ρ01 = 0.50 ρ01 = 0.50 ρ01 = 0.50 ρ01 = 0.50 ρ01 = 0.50 ρ01 = 0.50 ρ01 = 0.50 ρ01 = 0.50 ρ01 = 0.50 ρ01 = 0.50 ρ01 = 0.50
ρδσδ = 0 ρδσδ = -0.10 ρδσδ = -0.10 ρδσδ = 0 ρδσδ = -0.10 ρδσδ = -0.10 ρδσδ = 0 ρδσδ = -0.10 ρδσδ = -0.10 ρδσδ = 0 ρδσδ = -0.10 ρδσδ = -0.10
(1) (2) (3) (4) (5) (6) (1) (2) (3) (4) (5) (6)
I.  Normally Distributed Errors
  τHI 0.046 0.412 0.768 0.052 0.358 0.719 0.046 0.390 0.734 0.046 0.338 0.683
  τMB,0.05 0.100 0.379 0.713 0.108 0.326 0.653 0.125 0.385 0.730 0.115 0.352 0.680
  τMB,0.25 0.062 0.378 0.709 0.056 0.308 0.645 0.062 0.378 0.725 0.061 0.327 0.662
  τMB,EE,0.05 0.124 0.463 0.810 0.111 0.333 0.697 0.158 0.368 0.693 0.169 0.293 0.640
  τMB,EE,0.25 0.066 0.413 0.756 0.065 0.304 0.671 0.068 0.380 0.719 0.071 0.290 0.644
  τKV 0.361 0.369 0.369 0.361 0.370 0.373 0.258 0.254 0.268 0.258 0.262 0.275
  τBVN 0.288 0.262 0.261 0.213 0.220 0.266 0.253 0.266 0.284 0.191 0.238 0.325
  τMB-BC,0.05 0.299 0.271 0.264 0.298 0.274 0.271 0.276 0.262 0.302 0.283 0.297 0.321
  τMB-BC,0.25 0.284 0.259 0.264 0.284 0.263 0.263 0.246 0.253 0.289 0.252 0.275 0.299
  τBVN, EE 1.585 1.708 1.434 1.053 1.145 0.977 0.867 0.868 0.852 0.582 0.575 0.586
  τMB-BC,EE,0.05 1.389 1.431 1.375 1.383 1.471 1.243 0.794 0.942 0.973 0.731 0.743 0.802
  τMB-BC,EE,0.25 1.360 1.401 1.362 1.357 1.450 1.214 0.767 0.916 0.962 0.708 0.737 0.789
II.  Asymmetric, Non-Normally Distributed Errors
  τHI 0.045 0.380 0.604 0.051 0.287 0.443 0.044 0.366 0.607 0.046 0.287 0.465
  τMB,0.05 0.111 0.304 0.325 0.102 0.314 0.695 0.127 0.269 0.238 0.106 0.399 0.727
  τMB,0.25 0.056 0.311 0.401 0.051 0.272 0.632 0.063 0.305 0.400 0.060 0.362 0.662
  τMB,EE,0.05 0.124 0.496 0.774 0.120 0.242 0.443 0.159 0.417 0.609 0.151 0.294 0.470
  τMB,EE,0.25 0.067 0.397 0.621 0.066 0.210 0.440 0.065 0.368 0.554 0.068 0.275 0.465
  τKV 0.400 0.380 0.437 0.400 0.391 0.454 0.273 0.270 0.316 0.273 0.279 0.328
  τBVN 0.298 0.279 0.289 0.221 0.215 0.322 0.254 0.252 0.250 0.192 0.245 0.382
  τMB-BC,0.05 0.310 0.291 0.329 0.305 0.281 0.520 0.281 0.285 0.303 0.280 0.342 0.623
  τMB-BC,0.25 0.291 0.280 0.300 0.295 0.256 0.464 0.250 0.254 0.278 0.260 0.317 0.561
  τBVN, EE 1.405 1.641 1.772 0.931 1.075 1.155 0.861 0.953 0.915 0.566 0.630 0.631
  τMB-BC,EE,0.05 1.235 1.472 1.797 1.248 1.377 1.486 0.831 0.992 1.031 0.754 0.790 0.827
  τMB-BC,EE,0.25 1.206 1.484 1.860 1.221 1.369 1.456 0.810 0.976 1.014 0.733 0.771 0.779
Notes:  See Table 1.
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Table 3.  Summary Statistics
Variable Mean SD Mean SD Mean SD
SBP Participation (1 = Yes) 0.309 0.462 1 0 0 0
Third Grade Child Weight
   BMI Growth Rate 0.104 0.090 0.116 0.095 0.099 0.087
   Overweight (1 = Yes) 0.365 0.482 0.421 0.494 0.341 0.474
   Obese (1 = Yes) 0.197 0.398 0.238 0.426 0.179 0.383
Fifth Grade Child Weight
   BMI Growth Rate 0.198 0.122 0.222 0.123 0.188 0.119
   Overweight (1 = Yes) 0.414 0.493 0.492 0.500 0.380 0.485
   Obese (1 = Yes) 0.230 0.421 0.293 0.455 0.202 0.402
Controls
Age (in months) 109.448 4.334 109.578 4.468 109.390 4.271
Gender (1 = boy) 0.513 0.500 0.508 0.500 0.515 0.500
White (1 = Yes) 0.554 0.497 0.344 0.475 0.648 0.478
Black (1 = Yes) 0.137 0.344 0.269 0.444 0.078 0.268
Hispanic (1 = Yes) 0.191 0.393 0.265 0.442 0.157 0.364
Child's Birthweight (ounces) 117.066 26.044 115.256 27.249 117.873 25.449
Child's Birthweight (1 = Missing) 0.068 0.252 0.106 0.309 0.051 0.220
Central City (1 = Yes) 0.328 0.470 0.387 0.487 0.302 0.459
Urban Fringe & Large Town (1 = Yes) 0.388 0.487 0.260 0.438 0.445 0.497
Northeast (1 = Yes) 0.175 0.380 0.110 0.313 0.203 0.403
Midwest (1 = Yes) 0.239 0.426 0.188 0.391 0.261 0.439
South (1 = Yes) 0.338 0.473 0.464 0.499 0.281 0.450
Mother's Age at First Birth (Years) 23.567 5.090 21.290 4.232 24.584 5.111
Mother's Age at First Birth (1 = Missing) 0.117 0.321 0.164 0.370 0.095 0.294
WIC Benefits Prior to Kindergarten (1 = Yes) 0.460 0.498 0.733 0.443 0.338 0.473
WIC Benefits Prior to Kindergarten (1 = Missing) 0.031 0.173 0.046 0.209 0.024 0.154
Mother's Education = Less Than High 0.148 0.355 0.275 0.446 0.091 0.288
  School (1 = Yes)
Mother's Education = High School (1 = Yes) 0.312 0.463 0.376 0.484 0.284 0.451
Mother's Education = Some College (1 = Yes) 0.307 0.461 0.243 0.429 0.336 0.472
Mother's Education = Bachelor's 
  Degree (1 = Yes) 0.136 0.343 0.045 0.206 0.177 0.382
Mother's Education = Advanced College 
  Degree (1 = Yes) 0.065 0.247 0.016 0.125 0.087 0.282
Mother Employed Full-Time During 0.403 0.491 0.401 0.490 0.404 0.491
  Kindergarten (1 = Yes)
Mother Employed Part-Time During 0.189 0.391 0.131 0.337 0.214 0.410
  Kindergarten (1 = Yes)
No Mother in household During 0.288 0.453 0.309 0.462 0.278 0.448
  Kindergarten (1 = Yes)
SES Index -0.055 0.771 -0.490 0.678 0.139 0.729
SES Index (1 = Missing) 0.016 0.126 0.026 0.160 0.012 0.107
Never Worried About Running Out of Food in 0.793 0.405 0.687 0.464 0.841 0.366
  Household (1 = Yes)
Never Worried About Running Out of Food in 0.100 0.300 0.136 0.343 0.084 0.277
  Household (1 = Missing)
NSLP Participation (1 = Yes) 0.543 0.498 0.755 0.430 0.448 0.497
NSLP Participation (1 = Missing) 0.049 0.215 0.066 0.249 0.041 0.197
Number of Children's Books in Household 72.250 56.149 51.441 48.070 81.537 57.003
Number of Children's Books in Household 0.109 0.311 0.143 0.350 0.093 0.291
   (1 = Missing)
Notes: N = 9,952 (full sample for third grade outcomes); of this, 3,071 are SBP participants and 6,881 are non-participants.  Data are from the ECLS-K.   
Change in BMI percentile and BMI growth rate calculated using baseline data from first grade.  
Participants
SBP
Sample Non-Participants
Full SBP
Table 4.  Effect of SBP Participation on BMI Growth
Specification (1) Specification (2) Specification (3) Specification (1) Specification (2) Specification (3)
A.  ATE
  τOLS 0.007 0.007 0.007 0.013 0.013 0.012
[  0.003,  0.011] [  0.003,  0.011] [  0.003,  0.011] [  0.010,  0.021] [  0.011,  0.022] [  0.010,  0.021]
  τHI 0.011 0.010 0.010 0.023 0.025 0.024
[  0.006,  0.016] [  0.006,  0.015] [  0.005,  0.014] [  0.016,  0.031] [  0.017,  0.030] [  0.015,  0.029]
  τMB,0.05 0.003 0.006 0.006 0.018 0.023 0.019
[ -0.014,  0.020] [ -0.014,  0.019] [ -0.010,  0.016] [ -0.007,  0.033] [ -0.010,  0.034] [ -0.005,  0.034]
  τMB,0.25 0.004 0.005 0.007 0.011 0.012 0.012
[ -0.004,  0.009] [ -0.002,  0.009] [ -0.002,  0.010] [  0.002,  0.019] [  0.003,  0.020] [  0.003,  0.021]
  τKV -0.032 -0.029 -0.029 -0.031 -0.024 -0.021
[ -0.055, -0.004] [ -0.051,  0.004] [ -0.051,  0.005] [ -0.067,  0.014] [ -0.057,  0.024] [ -0.057,  0.031]
  τBVN -0.040 -0.032 -0.032 -0.065 -0.052 -0.044
[ -0.061, -0.013] [ -0.056, -0.002] [ -0.057, -0.003] [ -0.100, -0.024] [ -0.087, -0.003] [ -0.082,  0.007]
  τMB-BC,0.05 -0.042 -0.031 -0.031 -0.058 -0.040 -0.036
[ -0.077, -0.003] [ -0.069,  0.007] [ -0.063, -0.001] [ -0.108, -0.012] [ -0.092,  0.004] [ -0.088,  0.015]
  τMB-BC,0.25 -0.040 -0.032 -0.031 -0.065 -0.051 -0.043
[ -0.068, -0.011] [ -0.060,  0.000] [ -0.061, -0.001] [ -0.101, -0.018] [ -0.088,  0.007] [ -0.082,  0.012]
  P* 0.510 0.510 0.518 0.550 0.562 0.612
[  0.339,  0.815] [  0.293,  0.897] [  0.310,  0.927] [  0.403,  0.812] [  0.339,  0.919] [  0.357,  0.945]
B.  ATT
  τOLS 0.007 0.007 0.007 0.013 0.013 0.012
[  0.003,  0.011] [  0.003,  0.011] [  0.003,  0.011] [  0.010,  0.021] [  0.011,  0.022] [  0.010,  0.021]
  τHI 0.009 0.008 0.008 0.018 0.017 0.016
[  0.004,  0.014] [  0.004,  0.013] [  0.003,  0.013] [  0.012,  0.025] [  0.011,  0.024] [  0.010,  0.023]
  τMB,0.05 -0.001 0.000 0.002 0.018 0.018 0.020
[ -0.012,  0.014] [ -0.012,  0.015] [ -0.011,  0.017] [ -0.003,  0.035] [ -0.005,  0.037] [ -0.000,  0.039]
  τMB,0.25 0.005 0.006 0.006 0.011 0.012 0.013
[ -0.002,  0.009] [ -0.002,  0.010] [ -0.001,  0.011] [  0.005,  0.020] [  0.005,  0.023] [  0.005,  0.024]
  τKV -0.032 -0.029 -0.029 -0.031 -0.024 -0.021
[ -0.055, -0.004] [ -0.051,  0.004] [ -0.051,  0.005] [ -0.067,  0.014] [ -0.057,  0.024] [ -0.057,  0.031]
  τBVN -0.016 -0.012 -0.012 -0.022 -0.016 -0.012
[ -0.030, -0.000] [ -0.027,  0.005] [ -0.028,  0.004] [ -0.043,  0.002] [ -0.036,  0.010] [ -0.036,  0.015]
  τMB-BC,0.05 -0.046 -0.037 -0.034 -0.055 -0.042 -0.030
[ -0.076, -0.010] [ -0.066,  0.002] [ -0.066,  0.004] [ -0.100, -0.005] [ -0.086,  0.014] [ -0.081,  0.027]
  τMB-BC,0.25 -0.039 -0.031 -0.031 -0.062 -0.048 -0.037
[ -0.069, -0.011] [ -0.062,  0.001] [ -0.062,  0.001] [ -0.101, -0.012] [ -0.088,  0.013] [ -0.084,  0.017]
  P* 0.500 0.500 0.500 0.500 0.500 0.500
Notes: Treatment is defined as participation in SBP in first grade.  BMI growth measured from fall first grade. Specification 
(1) includes all variables from Table 3 entered linearly; Specification (2) adds squared and interaction terms for the 
continuous covariates; Specification (3) adds cubic and interaction terms for the continuous covariates.  90% empirical 
confidence intervals in brackets are obtained using 250 bootstrap repetitions.  OLS = ordinary least squares; HI = Hirano 
and Imbens (2001) normalized estimator; MB = minimum-biased estimator using θ = 0.0.5 or 0.25; KV = Klein and Vella 
(2009) estimator; BVN = Heckman bivariate normal selection model; MB-BC = bias-corrected estimator using θ = 0.0.5 or 
0.25; and, P* is the bias-minimizing propensity score.
Third Grade Outcome Fifth Grade Outcome
Table 5.  Effect of SBP Participation on the Probability of Being Overweight
Specification (1) Specification (2) Specification (3) Specification (1) Specification (2) Specification (3)
A.  ATE
  τOLS 0.036 0.035 0.035 0.050 0.050 0.049
[  0.015,  0.053] [  0.013,  0.053] [  0.014,  0.054] [  0.035,  0.081] [  0.029,  0.078] [  0.032,  0.076]
  τHI 0.061 0.048 0.048 0.081 0.081 0.076
[  0.036,  0.090] [  0.024,  0.077] [  0.027,  0.077] [  0.058,  0.117] [  0.045,  0.107] [  0.044,  0.106]
  τMB,0.05 0.034 0.054 0.003 0.058 0.037 0.057
[ -0.059,  0.088] [ -0.064,  0.083] [ -0.058,  0.094] [ -0.044,  0.119] [ -0.051,  0.122] [ -0.053,  0.116]
  τMB,0.25 0.025 0.011 0.016 0.034 0.035 0.030
[ -0.016,  0.038] [ -0.023,  0.042] [ -0.013,  0.049] [ -0.002,  0.065] [ -0.008,  0.069] [ -0.003,  0.065]
  τKV -0.144 -0.143 -0.136 -0.175 -0.197 -0.206
[ -0.282,  0.014] [ -0.274,  0.017] [ -0.283,  0.059] [ -0.320,  0.008] [ -0.353,  0.053] [ -0.359,  0.038]
  τBVN -0.231 -0.190 -0.208 -0.318 -0.279 -0.278
[ -0.388, -0.093] [ -0.333, -0.038] [ -0.329, -0.044] [ -0.460, -0.137] [ -0.418, -0.070] [ -0.397, -0.095]
  τMB-BC,0.05 -0.217 -0.159 -0.226 -0.295 -0.278 -0.255
[ -0.429, -0.033] [ -0.348, -0.023] [ -0.361, -0.019] [ -0.479, -0.094] [ -0.431, -0.035] [ -0.435, -0.060]
  τMB-BC,0.25 -0.226 -0.201 -0.213 -0.318 -0.281 -0.282
[ -0.396, -0.065] [ -0.331, -0.022] [ -0.332, -0.031] [ -0.478, -0.130] [ -0.424, -0.050] [ -0.397, -0.086]
  P* 0.538 0.514 0.502 0.538 0.526 0.534
[  0.372,  0.874] [  0.314,  0.880] [  0.314,  0.835] [  0.392,  0.812] [  0.343,  0.823] [  0.365,  0.818]
B.  ATT
  τOLS 0.036 0.035 0.035 0.050 0.050 0.049
[  0.015,  0.053] [  0.013,  0.053] [  0.014,  0.054] [  0.035,  0.081] [  0.029,  0.078] [  0.032,  0.076]
  τHI 0.038 0.037 0.034 0.055 0.051 0.049
[  0.016,  0.067] [  0.012,  0.062] [  0.009,  0.061] [  0.029,  0.086] [  0.023,  0.081] [  0.025,  0.078]
  τMB,0.05 0.009 0.020 -0.002 0.030 0.022 0.008
[ -0.057,  0.083] [ -0.044,  0.086] [ -0.044,  0.097] [ -0.050,  0.105] [ -0.051,  0.109] [ -0.053,  0.110]
  τMB,0.25 0.017 0.020 0.018 0.035 0.040 0.041
[ -0.019,  0.040] [ -0.015,  0.045] [ -0.018,  0.043] [  0.013,  0.077] [  0.009,  0.081] [  0.007,  0.077]
  τKV -0.144 -0.143 -0.136 -0.175 -0.197 -0.206
[ -0.282,  0.014] [ -0.274,  0.017] [ -0.283,  0.059] [ -0.320,  0.008] [ -0.353,  0.053] [ -0.359,  0.038]
  τBVN -0.094 -0.077 -0.088 -0.122 -0.107 -0.108
[ -0.183,  0.000] [ -0.156,  0.018] [ -0.163,  0.007] [ -0.210, -0.021] [ -0.191,  0.010] [ -0.182, -0.004]
  τMB-BC,0.05 -0.234 -0.190 -0.230 -0.311 -0.286 -0.296
[ -0.414, -0.041] [ -0.352,  0.003] [ -0.357, -0.021] [ -0.491, -0.084] [ -0.459, -0.018] [ -0.453, -0.027]
  τMB-BC,0.25 -0.226 -0.190 -0.211 -0.306 -0.269 -0.263
[ -0.411, -0.052] [ -0.358, -0.009] [ -0.361, -0.021] [ -0.472, -0.090] [ -0.433, -0.021] [ -0.413, -0.053]
  P* 0.500 0.500 0.500 0.500 0.500 0.500
Notes: Overweight is defined as BMI above the 85th percentile.  For other details, see Table 4.
Third Grade Outcome Fifth Grade Outcome
Table 6.  Effect of SBP Participation on the Probability of Being Obese
Specification (1) Specification (2) Specification (3) Specification (1) Specification (2) Specification (3)
A.  ATE
  τOLS 0.027 0.028 0.028 0.039 0.039 0.039
[  0.007,  0.038] [  0.006,  0.041] [  0.008,  0.043] [  0.019,  0.064] [  0.022,  0.066] [  0.024,  0.062]
  τHI 0.034 0.029 0.028 0.054 0.059 0.053
[  0.011,  0.056] [  0.008,  0.052] [  0.008,  0.049] [  0.030,  0.084] [  0.028,  0.087] [  0.026,  0.080]
  τMB,0.05 0.002 0.026 0.001 0.050 0.062 0.068
[ -0.063,  0.076] [ -0.055,  0.068] [ -0.063,  0.080] [ -0.045,  0.108] [ -0.046,  0.110] [ -0.031,  0.103]
  τMB,0.25 0.011 0.021 0.015 0.047 0.048 0.041
[ -0.017,  0.035] [ -0.016,  0.039] [ -0.015,  0.043] [ -0.009,  0.064] [ -0.002,  0.065] [ -0.005,  0.063]
  τKV -0.185 -0.150 -0.147 -0.119 -0.076 -0.098
[ -0.300, -0.058] [ -0.276, -0.005] [ -0.266,  0.006] [ -0.265,  0.029] [ -0.203,  0.089] [ -0.245,  0.066]
  τBVN -0.210 -0.158 -0.166 -0.192 -0.118 -0.134
[ -0.314, -0.103] [ -0.275, -0.032] [ -0.251, -0.026] [ -0.313, -0.040] [ -0.253,  0.038] [ -0.276,  0.015]
  τMB-BC,0.05 -0.222 -0.148 -0.182 -0.170 -0.088 -0.096
[ -0.341, -0.077] [ -0.304, -0.011] [ -0.288, -0.005] [ -0.350,  0.004] [ -0.283,  0.059] [ -0.293,  0.061]
  τMB-BC,0.25 -0.213 -0.154 -0.167 -0.173 -0.102 -0.123
[ -0.316, -0.097] [ -0.287, -0.027] [ -0.257, -0.011] [ -0.321, -0.026] [ -0.260,  0.037] [ -0.279,  0.044]
  P* 0.474 0.434 0.434 0.562 0.570 0.550
[  0.321,  0.728] [  0.243,  0.796] [  0.253,  0.850] [  0.361,  0.886] [  0.188,  0.943] [  0.199,  0.886]
B.  ATT
  τOLS 0.027 0.028 0.028 0.039 0.039 0.039
[  0.007,  0.038] [  0.006,  0.041] [  0.008,  0.043] [  0.019,  0.064] [  0.022,  0.066] [  0.024,  0.062]
  τHI 0.033 0.031 0.032 0.049 0.045 0.044
[  0.013,  0.051] [  0.007,  0.051] [  0.008,  0.052] [  0.021,  0.075] [  0.019,  0.071] [  0.022,  0.070]
  τMB,0.05 -0.003 0.012 0.016 0.059 0.025 0.044
[ -0.045,  0.071] [ -0.038,  0.081] [ -0.037,  0.105] [ -0.027,  0.112] [ -0.042,  0.117] [ -0.024,  0.119]
  τMB,0.25 0.020 0.021 0.023 0.039 0.041 0.043
[ -0.010,  0.039] [ -0.010,  0.038] [ -0.003,  0.048] [  0.006,  0.072] [  0.006,  0.071] [  0.011,  0.075]
  τKV -0.185 -0.150 -0.147 -0.119 -0.076 -0.098
[ -0.300, -0.058] [ -0.276, -0.005] [ -0.266,  0.006] [ -0.265,  0.029] [ -0.203,  0.089] [ -0.245,  0.066]
  τBVN -0.094 -0.071 -0.076 -0.068 -0.033 -0.043
[ -0.163, -0.034] [ -0.144,  0.000] [ -0.128,  0.009] [ -0.141,  0.016] [ -0.110,  0.059] [ -0.130,  0.047]
  τMB-BC,0.05 -0.232 -0.173 -0.178 -0.151 -0.117 -0.114
[ -0.365, -0.068] [ -0.310,  0.001] [ -0.277,  0.045] [ -0.339, -0.001] [ -0.284,  0.102] [ -0.301,  0.082]
  τMB-BC,0.25 -0.209 -0.164 -0.171 -0.171 -0.101 -0.115
[ -0.346, -0.089] [ -0.302, -0.025] [ -0.273, -0.006] [ -0.326, -0.003] [ -0.257,  0.091] [ -0.292,  0.070]
  P* 0.500 0.500 0.500 0.500 0.500 0.500
Notes: Obese is defined as BMI above the 95th percentile.  For other details, see Table 4.
Third Grade Outcome Fifth Grade Outcome
Table 7.  Effect of SBP Participation on the Probability of Being Underweight
Specification (1) Specification (2) Specification (3) Specification (1) Specification (2) Specification (3)
A.  ATE
  τOLS -0.020 -0.021 -0.020 -0.017 -0.018 -0.017
[ -0.031, -0.010] [ -0.031, -0.010] [ -0.029, -0.007] [ -0.029, -0.004] [ -0.030, -0.004] [ -0.028, -0.001]
  τHI -0.026 -0.025 -0.025 -0.032 -0.027 -0.025
[ -0.041, -0.015] [ -0.037, -0.012] [ -0.037, -0.010] [ -0.046, -0.015] [ -0.039, -0.011] [ -0.037, -0.008]
  τMB,0.05 -0.016 -0.018 -0.021 0.006 0.000 -0.004
[ -0.056,  0.021] [ -0.058,  0.024] [ -0.056,  0.022] [ -0.060,  0.035] [ -0.057,  0.028] [ -0.059,  0.030]
  τMB,0.25 -0.017 -0.016 -0.016 -0.010 -0.011 -0.011
[ -0.040, -0.000] [ -0.046, -0.001] [ -0.039,  0.001] [ -0.030,  0.006] [ -0.037,  0.005] [ -0.036,  0.010]
  τKV -0.007 -0.018 0.003 0.091 0.036 0.054
[ -0.085,  0.071] [ -0.105,  0.096] [ -0.102,  0.102] [ -0.005,  0.183] [ -0.073,  0.143] [ -0.065,  0.146]
  τBVN 0.018 0.002 0.016 0.115 0.048 0.054
[ -0.072,  0.104] [ -0.091,  0.098] [ -0.072,  0.096] [  0.013,  0.212] [ -0.057,  0.149] [ -0.046,  0.140]
  τMB-BC,0.05 0.019 -0.003 0.010 0.129 0.054 0.055
[ -0.077,  0.107] [ -0.089,  0.111] [ -0.079,  0.110] [  0.009,  0.215] [ -0.085,  0.144] [ -0.057,  0.144]
  τMB-BC,0.25 0.017 0.000 0.015 0.113 0.042 0.048
[ -0.073,  0.109] [ -0.092,  0.098] [ -0.061,  0.094] [ -0.006,  0.209] [ -0.059,  0.145] [ -0.044,  0.139]
  P* 0.679 0.880 0.711 0.577 0.793 0.747
[  0.046,  0.961] [  0.025,  0.961] [  0.023,  0.959] [  0.357,  0.926] [  0.145,  0.957] [  0.074,  0.972]
B.  ATT
  τOLS -0.020 -0.021 -0.020 -0.017 -0.018 -0.017
[ -0.031, -0.010] [ -0.031, -0.010] [ -0.029, -0.007] [ -0.029, -0.004] [ -0.030, -0.004] [ -0.028, -0.001]
  τHI -0.020 -0.017 -0.017 -0.020 -0.013 -0.011
[ -0.034, -0.007] [ -0.030, -0.006] [ -0.029, -0.005] [ -0.042, -0.000] [ -0.027,  0.002] [ -0.024,  0.004]
  τMB,0.05 -0.014 -0.024 -0.026 -0.019 -0.042 -0.042
[ -0.061,  0.015] [ -0.060,  0.020] [ -0.054,  0.020] [ -0.062,  0.023] [ -0.054,  0.029] [ -0.065,  0.020]
  τMB,0.25 -0.015 -0.018 -0.015 -0.009 -0.012 -0.015
[ -0.032,  0.001] [ -0.028,  0.002] [ -0.028,  0.004] [ -0.029,  0.009] [ -0.029,  0.007] [ -0.027,  0.008]
  τKV -0.007 -0.018 0.003 0.091 0.036 0.054
[ -0.085,  0.071] [ -0.105,  0.096] [ -0.102,  0.102] [ -0.005,  0.183] [ -0.073,  0.143] [ -0.065,  0.146]
  τBVN -0.003 -0.012 -0.004 0.044 0.008 0.012
[ -0.053,  0.052] [ -0.066,  0.046] [ -0.054,  0.044] [ -0.016,  0.101] [ -0.052,  0.069] [ -0.043,  0.066]
  τMB-BC,0.05 0.015 -0.013 0.000 0.097 0.000 0.007
[ -0.095,  0.114] [ -0.129,  0.111] [ -0.100,  0.109] [ -0.027,  0.219] [ -0.119,  0.137] [ -0.098,  0.133]
  τMB-BC,0.25 0.015 -0.007 0.012 0.106 0.029 0.034
[ -0.086,  0.115] [ -0.107,  0.111] [ -0.094,  0.107] [ -0.020,  0.226] [ -0.092,  0.151] [ -0.076,  0.138]
  P* 0.500 0.500 0.500 0.500 0.500 0.500
Notes: Underweight is defined as BMI below the 20th percentile.  For other details, see Table 4.
Third Grade Outcome Fifth Grade Outcome
Table A1.  Monte Carlo Results: Estimates in the Common Effect Model ( ρ 0σ0 = 0; ρ01 = 1)
(1) (2) (3) (4) (1) (2) (3) (4) (1) (2) (3) (4) (1) (2) (3) (4)
I.  Normally Distributed Errors
  τHI 0.617 0.047 0.047 0.048 0.564 0.053 0.052 0.053 0.619 0.047 0.043 0.043 0.570 0.048 0.044 0.045
  τMB,0.05 0.342 0.113 0.122 0.111 0.231 0.102 0.100 0.106 0.331 0.138 0.103 0.101 0.725 0.114 0.110 0.106
  τMB,0.25 0.383 0.064 0.055 0.056 0.587 0.056 0.054 0.053 0.357 0.060 0.056 0.057 0.771 0.060 0.052 0.053
  τMB,EE,0.05 0.281 0.129 0.129 0.129 0.380 0.123 0.134 0.124 0.571 0.176 0.121 0.118 0.361 0.169 0.115 0.113
  τMB,EE,0.25 0.537 0.068 0.067 0.068 0.389 0.067 0.071 0.071 0.671 0.071 0.061 0.062 0.458 0.070 0.061 0.062
  τKV 3.312 0.360 0.428 0.406 3.312 0.360 0.428 0.406 3.238 0.238 0.316 0.309 3.238 0.238 0.316 0.309
  τBVN 17.906 0.301 0.335 0.328 11.696 0.226 0.249 0.243 10.622 0.232 0.261 0.261 7.139 0.177 0.201 0.200
  τMB-BC,0.05 17.304 0.312 0.354 0.341 15.478 0.321 0.345 0.341 10.038 0.257 0.267 0.265 9.453 0.259 0.302 0.296
  τMB-BC,0.25 17.357 0.296 0.326 0.321 15.855 0.307 0.331 0.324 10.099 0.225 0.250 0.248 9.544 0.240 0.274 0.273
  τBVN, EE 195.750 1.610 1.543 1.514 102.382 1.068 1.078 1.052 533.206 0.828 0.863 0.823 321.761 0.548 0.749 0.711
  τMB-BC,EE,0.05 194.989 1.319 1.384 1.338 147.330 1.381 1.338 1.350 533.022 0.730 1.146 1.151 452.463 0.688 0.875 0.864
  τMB-BC,EE,0.25 194.718 1.289 1.352 1.309 147.343 1.348 1.315 1.323 533.118 0.698 1.118 1.131 452.561 0.673 0.852 0.843
II.  Asymmetric, Non-Normally Distributed Errors
  τHI 0.615 0.050 0.047 0.048 0.562 0.055 0.052 0.051 0.616 0.048 0.043 0.043 0.567 0.051 0.047 0.047
  τMB,0.05 0.332 0.097 0.107 0.105 0.218 0.100 0.105 0.113 0.385 0.125 0.109 0.111 0.728 0.112 0.103 0.111
  τMB,0.25 0.377 0.059 0.056 0.055 0.587 0.055 0.052 0.055 0.386 0.064 0.056 0.057 0.763 0.059 0.054 0.051
  τMB,EE,0.05 0.291 0.130 0.127 0.128 0.357 0.128 0.127 0.126 0.596 0.171 0.128 0.133 0.344 0.161 0.125 0.123
  τMB,EE,0.25 0.548 0.069 0.067 0.068 0.400 0.069 0.069 0.070 0.691 0.069 0.059 0.064 0.455 0.067 0.063 0.063
  τKV 3.308 0.363 0.441 0.408 3.308 0.363 0.441 0.408 3.233 0.248 0.329 0.318 3.233 0.248 0.329 0.318
  τBVN 17.093 0.281 0.322 0.315 11.200 0.207 0.236 0.232 10.158 0.245 0.269 0.260 6.842 0.184 0.204 0.198
  τMB-BC,0.05 16.487 0.286 0.340 0.329 14.768 0.289 0.329 0.338 9.612 0.273 0.285 0.279 9.061 0.257 0.290 0.288
  τMB-BC,0.25 16.542 0.277 0.319 0.311 15.159 0.278 0.312 0.309 9.657 0.242 0.265 0.255 9.142 0.248 0.276 0.267
  τBVN, EE 171.703 1.608 1.610 1.526 89.061 1.071 1.105 1.047 501.755 0.899 0.923 0.866 303.361 0.598 0.786 0.736
  τMB-BC,EE,0.05 170.746 1.329 1.435 1.373 128.059 1.401 1.419 1.322 501.488 0.838 0.995 0.917 426.283 0.787 0.894 0.853
  τMB-BC,EE,0.25 170.477 1.296 1.405 1.342 128.073 1.377 1.390 1.285 501.588 0.815 0.970 0.894 426.399 0.762 0.878 0.833
Notes: Specification (1) is under-specified (relevant higher order terms are excluded); specification (2) is correctly specified; specification (3) is over-specified (irrelevant higher order terms are included); 
specification (4) is over-specified (irrelevant higher order terms and an irrelevant variable are included).  Shading indicates best performance within each column.  See text and Table 1 for further details. 
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Table A2.  Monte Carlo Results: Estimates in the Common Effect Model ( ρ 0σ0 = -0.25; ρ01 = 1)
(1) (2) (3) (4) (1) (2) (3) (4) (1) (2) (3) (4) (1) (2) (3) (4)
I.  Normally Distributed Errors
  τHI 0.962 0.440 0.441 0.441 0.915 0.443 0.446 0.446 0.959 0.415 0.442 0.442 0.914 0.421 0.441 0.441
  τMB,0.05 0.724 0.407 0.399 0.403 0.582 0.411 0.413 0.409 0.742 0.406 0.410 0.405 1.058 0.432 0.411 0.411
  τMB,0.25 0.764 0.402 0.401 0.403 0.922 0.404 0.404 0.404 0.762 0.410 0.406 0.405 1.098 0.428 0.405 0.404
  τMB,EE,0.05 0.576 0.471 0.459 0.468 0.757 0.464 0.467 0.474 0.916 0.388 0.454 0.457 0.734 0.420 0.470 0.455
  τMB,EE,0.25 0.858 0.437 0.434 0.438 0.758 0.437 0.451 0.450 1.001 0.411 0.428 0.429 0.819 0.421 0.448 0.442
  τKV 3.308 0.374 0.463 0.439 3.308 0.374 0.463 0.439 3.239 0.279 0.372 0.359 3.239 0.279 0.372 0.359
  τBVN 15.800 0.287 0.324 0.322 10.481 0.245 0.267 0.270 9.046 0.265 0.271 0.274 6.243 0.259 0.242 0.247
  τMB-BC,0.05 15.283 0.301 0.336 0.342 13.692 0.296 0.323 0.314 8.580 0.266 0.295 0.291 8.132 0.294 0.289 0.291
  τMB-BC,0.25 15.325 0.291 0.326 0.322 14.037 0.283 0.313 0.310 8.619 0.264 0.277 0.277 8.209 0.278 0.273 0.276
  τBVN, EE 192.679 1.363 1.380 1.372 101.120 0.933 0.982 0.974 462.362 0.903 0.956 0.897 279.601 0.617 0.829 0.776
  τMB-BC,EE,0.05 192.262 1.268 1.435 1.494 145.840 1.185 1.219 1.205 462.119 0.823 1.213 1.196 392.971 0.761 0.965 0.963
  τMB-BC,EE,0.25 191.988 1.244 1.414 1.474 145.854 1.171 1.193 1.183 462.193 0.803 1.194 1.181 393.048 0.746 0.947 0.944
II.  Asymmetric, Non-Normally Distributed Errors
  τHI 0.918 0.378 0.377 0.377 0.866 0.348 0.350 0.349 0.918 0.364 0.388 0.388 0.867 0.339 0.356 0.357
  τMB,0.05 0.628 0.350 0.354 0.352 0.619 0.420 0.419 0.420 0.847 0.338 0.369 0.368 1.074 0.439 0.418 0.425
  τMB,0.25 0.697 0.348 0.350 0.350 0.917 0.387 0.387 0.388 0.849 0.346 0.357 0.355 1.101 0.409 0.385 0.385
  τMB,EE,0.05 0.497 0.434 0.440 0.429 0.655 0.348 0.361 0.350 1.037 0.344 0.426 0.436 0.637 0.325 0.344 0.362
  τMB,EE,0.25 0.743 0.385 0.386 0.383 0.676 0.338 0.344 0.341 1.101 0.354 0.385 0.387 0.749 0.329 0.343 0.347
  τKV 3.312 0.400 0.441 0.425 3.312 0.400 0.441 0.425 3.243 0.275 0.329 0.328 3.243 0.275 0.329 0.328
  τBVN 14.677 0.308 0.348 0.341 9.828 0.300 0.317 0.314 8.226 0.288 0.292 0.293 5.748 0.300 0.305 0.307
  τMB-BC,0.05 14.108 0.313 0.343 0.344 12.891 0.381 0.407 0.404 7.838 0.294 0.310 0.301 7.544 0.395 0.389 0.396
  τMB-BC,0.25 14.179 0.303 0.338 0.333 13.195 0.350 0.376 0.372 7.874 0.285 0.289 0.288 7.606 0.363 0.358 0.361
  τBVN, EE 210.248 1.631 1.588 1.560 111.527 1.083 1.081 1.067 455.459 0.900 0.765 0.758 275.333 0.590 0.659 0.655
  τMB-BC,EE,0.05 210.027 1.514 1.592 1.447 160.829 1.389 1.370 1.326 454.976 0.903 1.177 1.130 387.099 0.774 0.762 0.751
  τMB-BC,EE,0.25 209.796 1.503 1.584 1.436 160.827 1.374 1.358 1.317 455.038 0.872 1.178 1.133 387.204 0.749 0.759 0.736
Notes:  See Table A1.
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Table A3.  Monte Carlo Results: Estimates in the Common Effect Model ( ρ 0σ0 = -0.50; ρ01 = 1)
(1) (2) (3) (4) (1) (2) (3) (4) (1) (2) (3) (4) (1) (2) (3) (4)
I.  Normally Distributed Errors
  τHI 1.306 0.883 0.881 0.882 1.266 0.893 0.891 0.892 1.298 0.841 0.873 0.872 1.256 0.844 0.874 0.874
  τMB,0.05 1.109 0.795 0.796 0.803 0.967 0.800 0.801 0.798 1.130 0.817 0.798 0.805 1.388 0.817 0.800 0.808
  τMB,0.25 1.149 0.805 0.805 0.804 1.261 0.809 0.808 0.808 1.149 0.823 0.808 0.810 1.435 0.831 0.810 0.812
  τMB,EE,0.05 0.906 0.892 0.885 0.900 1.165 0.898 0.903 0.907 1.212 0.788 0.874 0.869 1.110 0.819 0.870 0.880
  τMB,EE,0.25 1.169 0.860 0.856 0.863 1.138 0.864 0.872 0.875 1.288 0.829 0.851 0.847 1.170 0.836 0.860 0.859
  τKV 3.301 0.368 0.418 0.422 3.301 0.368 0.418 0.422 3.232 0.269 0.335 0.340 3.232 0.269 0.335 0.340
  τBVN 14.099 0.278 0.299 0.302 9.518 0.312 0.328 0.338 8.264 0.300 0.271 0.276 5.853 0.394 0.335 0.345
  τMB-BC,0.05 13.665 0.287 0.322 0.324 12.280 0.294 0.308 0.307 7.874 0.317 0.286 0.303 7.493 0.334 0.290 0.294
  τMB-BC,0.25 13.703 0.285 0.308 0.312 12.574 0.277 0.291 0.294 7.913 0.314 0.280 0.286 7.567 0.328 0.276 0.282
  τBVN, EE 207.023 1.402 1.417 1.385 109.571 0.964 1.002 0.999 400.614 0.835 0.819 0.776 242.912 0.585 0.738 0.712
  τMB-BC,EE,0.05 206.831 1.422 1.526 1.482 158.241 1.247 1.248 1.220 400.363 0.791 1.045 1.065 341.154 0.731 0.922 0.853
  τMB-BC,EE,0.25 206.585 1.396 1.501 1.451 158.267 1.223 1.222 1.187 400.429 0.781 1.037 1.062 341.202 0.733 0.909 0.842
II.  Asymmetric, Non-Normally Distributed Errors
  τHI 1.143 0.628 0.628 0.626 1.082 0.489 0.488 0.486 1.148 0.641 0.669 0.669 1.087 0.511 0.533 0.532
  τMB,0.05 1.288 0.391 0.361 0.357 1.087 0.784 0.781 0.781 1.411 0.348 0.475 0.475 1.411 0.806 0.783 0.788
  τMB,0.25 1.265 0.449 0.428 0.434 1.228 0.715 0.714 0.711 1.346 0.446 0.498 0.498 1.410 0.731 0.710 0.709
  τMB,EE,0.05 0.707 0.792 0.762 0.765 0.727 0.518 0.511 0.501 1.655 0.616 0.589 0.654 0.804 0.487 0.478 0.536
  τMB,EE,0.25 0.926 0.648 0.631 0.634 0.768 0.496 0.483 0.490 1.503 0.571 0.560 0.594 0.963 0.492 0.482 0.511
  τKV 3.310 0.368 0.484 0.446 3.310 0.368 0.484 0.446 3.236 0.257 0.335 0.323 3.236 0.257 0.335 0.323
  τBVN 7.641 0.380 0.370 0.372 5.635 0.585 0.528 0.533 3.816 0.364 0.424 0.426 3.036 0.572 0.647 0.648
  τMB-BC,0.05 7.333 0.378 0.389 0.383 7.321 0.868 0.812 0.820 3.775 0.373 0.460 0.457 3.968 0.866 0.966 0.972
  τMB-BC,0.25 7.373 0.396 0.376 0.380 7.465 0.801 0.748 0.753 3.732 0.390 0.467 0.466 4.004 0.794 0.896 0.896
  τBVN, EE 266.352 1.819 1.707 1.674 144.190 1.172 1.101 1.101 345.781 1.080 0.730 0.740 210.121 0.700 0.673 0.704
  τMB-BC,EE,0.05 266.189 1.764 1.810 1.599 208.051 1.514 1.418 1.403 343.166 1.169 0.872 0.902 295.415 0.956 0.755 0.819
  τMB-BC,EE,0.25 265.986 1.786 1.839 1.624 207.986 1.443 1.360 1.369 343.034 1.125 0.892 0.918 295.549 0.874 0.748 0.811
Notes:  See Table A1.
ATT
Homoskedastic Error in Treatment Equation Heteroskedastic Error in Treatment Equation
ATE ATT ATE
Table A4.  Monte Carlo Results: Estimates in the Heterogeneous Effect Model ( ρ 0σ0 = 0; ρ01 = 0.50; ρδσδ = 0)
(1) (2) (3) (4) (1) (2) (3) (4) (1) (2) (3) (4) (1) (2) (3) (4)
I.  Normally Distributed Errors
  τHI 0.615 0.046 0.043 0.044 0.561 0.052 0.049 0.050 0.618 0.046 0.040 0.040 0.569 0.046 0.043 0.043
  τMB,0.05 0.345 0.100 0.107 0.103 0.232 0.108 0.107 0.110 0.356 0.125 0.103 0.116 0.731 0.115 0.112 0.110
  τMB,0.25 0.382 0.062 0.060 0.063 0.590 0.056 0.058 0.057 0.374 0.062 0.055 0.056 0.768 0.061 0.055 0.054
  τMB,EE,0.05 0.285 0.124 0.130 0.129 0.349 0.111 0.121 0.120 0.572 0.158 0.116 0.115 0.365 0.169 0.119 0.116
  τMB,EE,0.25 0.540 0.066 0.062 0.064 0.384 0.065 0.064 0.065 0.686 0.068 0.062 0.061 0.454 0.071 0.058 0.056
  τKV 3.304 0.361 0.450 0.426 3.304 0.361 0.450 0.426 3.237 0.258 0.342 0.328 3.237 0.258 0.342 0.328
  τBVN 17.500 0.288 0.325 0.322 11.449 0.213 0.239 0.237 10.454 0.253 0.271 0.268 7.034 0.191 0.208 0.206
  τMB-BC,0.05 16.904 0.299 0.339 0.335 15.157 0.298 0.324 0.326 9.898 0.276 0.275 0.280 9.350 0.283 0.299 0.295
  τMB-BC,0.25 16.951 0.284 0.319 0.313 15.538 0.284 0.318 0.315 9.945 0.246 0.260 0.259 9.415 0.252 0.278 0.274
  τBVN, EE 188.928 1.585 1.575 1.539 98.698 1.053 1.080 1.066 528.207 0.867 0.959 0.912 318.666 0.582 0.822 0.783
  τMB-BC,EE,0.05 187.976 1.389 1.413 1.442 142.308 1.383 1.360 1.357 528.023 0.794 1.086 1.067 448.563 0.731 0.945 0.926
  τMB-BC,EE,0.25 187.702 1.360 1.377 1.407 142.308 1.357 1.334 1.323 528.138 0.767 1.073 1.054 448.653 0.708 0.925 0.904
II.  Asymmetric, Non-Normally Distributed Errors
  τHI 0.616 0.045 0.043 0.043 0.562 0.051 0.050 0.050 0.619 0.044 0.040 0.040 0.569 0.046 0.042 0.043
  τMB,0.05 0.339 0.111 0.107 0.105 0.221 0.102 0.108 0.113 0.367 0.127 0.107 0.103 0.729 0.106 0.105 0.110
  τMB,0.25 0.383 0.056 0.056 0.056 0.589 0.051 0.052 0.050 0.371 0.063 0.056 0.056 0.771 0.060 0.053 0.053
  τMB,EE,0.05 0.280 0.124 0.120 0.119 0.377 0.120 0.121 0.119 0.562 0.159 0.116 0.113 0.358 0.151 0.122 0.117
  τMB,EE,0.25 0.533 0.067 0.063 0.061 0.393 0.066 0.066 0.068 0.670 0.065 0.060 0.059 0.460 0.068 0.061 0.063
  τKV 3.306 0.400 0.493 0.440 3.306 0.400 0.493 0.440 3.233 0.273 0.363 0.351 3.233 0.273 0.363 0.351
  τBVN 17.484 0.298 0.328 0.318 11.438 0.221 0.242 0.234 10.559 0.254 0.282 0.275 7.105 0.192 0.215 0.209
  τMB-BC,0.05 16.882 0.310 0.342 0.321 15.115 0.305 0.334 0.327 10.003 0.281 0.288 0.281 9.418 0.280 0.307 0.308
  τMB-BC,0.25 16.934 0.291 0.320 0.310 15.503 0.295 0.320 0.309 10.041 0.250 0.270 0.265 9.499 0.260 0.287 0.280
  τBVN, EE 174.035 1.405 1.414 1.358 89.977 0.931 0.974 0.934 529.111 0.861 0.850 0.796 318.996 0.566 0.747 0.695
  τMB-BC,EE,0.05 173.154 1.235 1.312 1.312 129.674 1.248 1.223 1.185 528.875 0.831 1.130 1.017 449.411 0.754 0.878 0.793
  τMB-BC,EE,0.25 172.881 1.206 1.289 1.290 129.696 1.221 1.199 1.164 528.977 0.810 1.112 0.998 449.510 0.733 0.855 0.770
Notes:  See Table A1.
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Table A5.  Monte Carlo Results: Estimates in the Heterogeneous Effect Model ( ρ 0σ0 = -0.20; ρ01 = 0.50; ρδσδ = -0.10)
(1) (2) (3) (4) (1) (2) (3) (4) (1) (2) (3) (4) (1) (2) (3) (4)
I.  Normally Distributed Errors
  τHI 0.935 0.412 0.412 0.413 0.842 0.358 0.357 0.358 0.933 0.390 0.415 0.416 0.843 0.338 0.358 0.359
  τMB,0.05 0.657 0.379 0.383 0.388 0.520 0.326 0.325 0.326 0.772 0.385 0.392 0.388 0.979 0.352 0.322 0.325
  τMB,0.25 0.720 0.378 0.375 0.376 0.828 0.308 0.307 0.306 0.785 0.378 0.377 0.374 1.007 0.327 0.303 0.302
  τMB,EE,0.05 0.534 0.463 0.468 0.466 0.619 0.333 0.342 0.340 0.938 0.368 0.448 0.447 0.593 0.293 0.338 0.338
  τMB,EE,0.25 0.790 0.413 0.410 0.412 0.618 0.304 0.312 0.314 1.036 0.380 0.407 0.409 0.694 0.290 0.313 0.314
  τKV 3.316 0.369 0.461 0.440 3.272 0.370 0.466 0.440 3.231 0.254 0.321 0.315 3.189 0.262 0.332 0.322
  τBVN 14.691 0.262 0.311 0.311 9.768 0.220 0.244 0.248 8.343 0.266 0.259 0.258 5.776 0.238 0.218 0.220
  τMB-BC,0.05 14.144 0.271 0.318 0.316 12.750 0.274 0.320 0.315 7.911 0.262 0.277 0.283 7.524 0.297 0.279 0.281
  τMB-BC,0.25 14.207 0.259 0.306 0.307 13.063 0.263 0.302 0.302 7.955 0.253 0.263 0.261 7.586 0.275 0.269 0.269
  τBVN, EE 192.651 1.708 1.621 1.558 101.254 1.145 1.121 1.072 450.245 0.868 0.813 0.769 272.382 0.575 0.709 0.671
  τMB-BC,EE,0.05 192.470 1.431 1.517 1.490 146.116 1.471 1.420 1.334 449.932 0.942 1.208 1.128 382.924 0.743 0.803 0.770
  τMB-BC,EE,0.25 192.225 1.401 1.499 1.474 146.130 1.450 1.391 1.315 450.023 0.916 1.200 1.125 383.016 0.737 0.785 0.754
II.  Asymmetric, Non-Normally Distributed Errors
  τHI 0.908 0.380 0.379 0.379 0.806 0.287 0.287 0.287 0.907 0.366 0.390 0.391 0.821 0.287 0.309 0.309
  τMB,0.05 0.597 0.304 0.312 0.311 0.546 0.314 0.315 0.317 0.958 0.269 0.338 0.337 1.040 0.399 0.384 0.381
  τMB,0.25 0.702 0.311 0.313 0.315 0.820 0.272 0.272 0.271 0.944 0.305 0.330 0.329 1.065 0.362 0.340 0.338
  τMB,EE,0.05 0.472 0.496 0.482 0.492 0.539 0.242 0.234 0.231 1.140 0.417 0.478 0.478 0.579 0.294 0.303 0.314
  τMB,EE,0.25 0.709 0.397 0.392 0.395 0.544 0.210 0.212 0.209 1.169 0.368 0.391 0.396 0.697 0.275 0.284 0.285
  τKV 3.286 0.380 0.446 0.422 3.241 0.391 0.453 0.426 3.209 0.270 0.337 0.315 3.178 0.279 0.345 0.321
  τBVN 12.827 0.279 0.342 0.340 8.675 0.215 0.244 0.247 7.240 0.252 0.253 0.250 5.129 0.245 0.248 0.248
  τMB-BC,0.05 12.233 0.291 0.342 0.341 11.311 0.281 0.322 0.329 6.962 0.285 0.267 0.262 6.749 0.342 0.350 0.351
  τMB-BC,0.25 12.336 0.280 0.336 0.332 11.593 0.256 0.296 0.301 6.980 0.254 0.260 0.258 6.809 0.317 0.310 0.310
  τBVN, EE 221.506 1.641 1.592 1.551 117.753 1.075 1.063 1.037 422.570 0.953 0.819 0.793 256.358 0.630 0.708 0.687
  τMB-BC,EE,0.05 221.399 1.472 1.452 1.426 169.958 1.377 1.350 1.280 421.728 0.992 1.168 1.059 360.191 0.790 0.819 0.775
  τMB-BC,EE,0.25 221.175 1.484 1.453 1.431 169.955 1.369 1.332 1.263 421.760 0.976 1.182 1.069 360.294 0.771 0.816 0.774
Notes:  See Table A1.
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Table A6.  Monte Carlo Results: Estimates in the Heterogeneous Effect Model ( ρ 0σ0 = -0.40; ρ01 = 0.50; ρδσδ = -0.10)
(1) (2) (3) (4) (1) (2) (3) (4) (1) (2) (3) (4) (1) (2) (3) (4)
I.  Normally Distributed Errors
  τHI 1.217 0.768 0.769 0.769 1.128 0.719 0.720 0.719 1.209 0.734 0.768 0.767 1.122 0.683 0.715 0.715
  τMB,0.05 0.962 0.713 0.718 0.716 0.830 0.653 0.659 0.654 1.146 0.730 0.701 0.704 1.262 0.680 0.656 0.659
  τMB,0.25 1.029 0.709 0.710 0.711 1.116 0.645 0.644 0.644 1.135 0.725 0.705 0.705 1.290 0.662 0.641 0.641
  τMB,EE,0.05 0.826 0.810 0.814 0.815 0.950 0.697 0.703 0.708 1.231 0.693 0.776 0.781 0.923 0.640 0.697 0.698
  τMB,EE,0.25 1.061 0.756 0.760 0.759 0.941 0.671 0.678 0.674 1.296 0.719 0.747 0.745 0.999 0.644 0.671 0.668
  τKV 3.299 0.369 0.455 0.442 3.256 0.373 0.452 0.434 3.228 0.268 0.359 0.345 3.187 0.275 0.363 0.344
  τBVN 13.197 0.261 0.301 0.305 8.918 0.266 0.301 0.311 7.527 0.284 0.267 0.270 5.343 0.325 0.286 0.294
  τMB-BC,0.05 12.705 0.264 0.321 0.326 11.520 0.271 0.308 0.312 7.208 0.302 0.284 0.292 6.875 0.321 0.285 0.299
  τMB-BC,0.25 12.772 0.264 0.307 0.309 11.808 0.263 0.295 0.302 7.223 0.289 0.270 0.274 6.929 0.299 0.272 0.273
  τBVN, EE 211.512 1.434 1.514 1.424 112.134 0.977 1.054 1.007 403.337 0.852 0.832 0.786 244.920 0.586 0.731 0.701
  τMB-BC,EE,0.05 211.378 1.375 1.471 1.343 162.320 1.243 1.321 1.274 402.984 0.973 1.069 1.003 343.887 0.802 0.888 0.833
  τMB-BC,EE,0.25 211.160 1.362 1.448 1.324 162.326 1.214 1.295 1.249 403.036 0.962 1.063 1.000 343.953 0.789 0.874 0.826
II.  Asymmetric, Non-Normally Distributed Errors
  τHI 1.095 0.604 0.604 0.604 0.997 0.443 0.444 0.444 1.099 0.607 0.635 0.634 1.014 0.465 0.486 0.486
  τMB,0.05 1.202 0.325 0.322 0.327 1.004 0.695 0.692 0.689 1.340 0.238 0.395 0.404 1.345 0.727 0.706 0.698
  τMB,0.25 1.195 0.401 0.401 0.402 1.156 0.632 0.630 0.628 1.283 0.400 0.445 0.448 1.347 0.662 0.640 0.639
  τMB,EE,0.05 0.660 0.774 0.791 0.794 0.714 0.443 0.475 0.461 1.603 0.609 0.660 0.687 0.768 0.470 0.493 0.479
  τMB,EE,0.25 0.878 0.621 0.629 0.631 0.732 0.440 0.446 0.441 1.441 0.554 0.587 0.597 0.923 0.465 0.471 0.464
  τKV 3.252 0.437 0.491 0.442 3.214 0.454 0.504 0.449 3.174 0.316 0.398 0.371 3.149 0.328 0.408 0.378
  τBVN 7.792 0.289 0.372 0.357 5.668 0.322 0.299 0.307 3.597 0.250 0.287 0.289 2.851 0.382 0.432 0.438
  τMB-BC,0.05 7.460 0.329 0.406 0.393 7.403 0.520 0.496 0.506 3.589 0.303 0.318 0.327 3.750 0.623 0.684 0.685
  τMB-BC,0.25 7.521 0.300 0.369 0.355 7.555 0.464 0.441 0.451 3.530 0.278 0.339 0.345 3.784 0.561 0.621 0.627
  τBVN, EE 271.652 1.772 1.731 1.675 146.545 1.155 1.135 1.107 347.390 0.915 0.757 0.744 211.714 0.631 0.677 0.679
  τMB-BC,EE,0.05 271.501 1.797 1.838 1.629 211.451 1.486 1.436 1.396 344.602 1.031 1.174 1.196 297.136 0.827 0.797 0.788
  τMB-BC,EE,0.25 271.297 1.860 1.897 1.675 211.408 1.456 1.399 1.373 344.461 1.014 1.216 1.252 297.267 0.779 0.776 0.772
Notes:  See Table A1.
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Table B1.  Monte Carlo Results: Estimates in the Common Effect Model ( ρ 0σ0 = 0; ρ01 = 1)
(1) (2) (3) (4) (1) (2) (3) (4) (1) (2) (3) (4) (1) (2) (3) (4)
I.  Normally Distributed Errors
  τHI 0.614 0.006 0.007 0.006 0.560 0.008 0.008 0.008 0.616 0.014 0.011 0.011 0.566 0.009 0.009 0.009
  τMB,0.05 0.312 0.017 0.016 0.016 0.199 0.019 0.020 0.018 0.222 0.050 0.022 0.023 0.722 0.032 0.018 0.018
  τMB,0.25 0.380 0.008 0.008 0.008 0.591 0.007 0.007 0.007 0.284 0.023 0.013 0.013 0.770 0.027 0.007 0.007
  τMB,EE,0.05 0.278 0.020 0.018 0.018 0.416 0.016 0.019 0.018 0.389 0.093 0.030 0.032 0.341 0.098 0.026 0.025
  τMB,EE,0.25 0.532 0.011 0.009 0.009 0.329 0.009 0.009 0.009 0.536 0.019 0.015 0.016 0.429 0.030 0.012 0.012
  τKV 3.310 0.051 0.053 0.053 3.310 0.051 0.053 0.053 3.237 0.033 0.043 0.043 3.237 0.033 0.043 0.043
  τBVN 17.237 0.037 0.040 0.039 11.295 0.028 0.030 0.029 10.181 0.036 0.039 0.039 6.878 0.028 0.031 0.031
  τMB-BC,0.05 16.616 0.040 0.042 0.043 14.915 0.043 0.047 0.046 9.563 0.061 0.045 0.045 9.163 0.049 0.049 0.048
  τMB-BC,0.25 16.683 0.037 0.039 0.039 15.308 0.037 0.040 0.040 9.625 0.042 0.038 0.038 9.211 0.043 0.042 0.041
  τBVN, EE 164.133 0.257 0.253 0.252 83.643 0.170 0.168 0.167 475.238 0.122 0.127 0.127 288.444 0.079 0.112 0.112
  τMB-BC,EE,0.05 163.422 0.204 0.217 0.228 120.067 0.216 0.211 0.211 475.021 0.134 0.177 0.180 404.771 0.145 0.130 0.132
  τMB-BC,EE,0.25 163.145 0.199 0.213 0.223 120.154 0.214 0.211 0.210 475.168 0.091 0.174 0.176 404.858 0.104 0.125 0.128
II.  Asymmetric, Non-Normally Distributed Errors
  τHI 0.613 0.006 0.006 0.006 0.559 0.007 0.007 0.007 0.615 0.016 0.008 0.008 0.565 0.010 0.007 0.007
  τMB,0.05 0.312 0.014 0.016 0.015 0.199 0.015 0.015 0.015 0.221 0.063 0.020 0.021 0.732 0.032 0.014 0.013
  τMB,0.25 0.379 0.007 0.008 0.008 0.592 0.007 0.007 0.007 0.281 0.024 0.012 0.012 0.770 0.025 0.007 0.007
  τMB,EE,0.05 0.299 0.017 0.016 0.018 0.414 0.018 0.017 0.017 0.389 0.105 0.026 0.026 0.342 0.092 0.028 0.027
  τMB,EE,0.25 0.551 0.009 0.008 0.008 0.327 0.009 0.009 0.009 0.537 0.022 0.013 0.013 0.431 0.027 0.013 0.013
  τKV 3.307 0.050 0.058 0.058 3.307 0.050 0.058 0.058 3.236 0.039 0.047 0.047 3.236 0.039 0.047 0.047
  τBVN 17.324 0.034 0.040 0.040 11.346 0.024 0.029 0.028 10.064 0.033 0.035 0.035 6.801 0.024 0.026 0.026
  τMB-BC,0.05 16.704 0.037 0.043 0.043 14.991 0.033 0.039 0.038 9.449 0.068 0.038 0.038 9.074 0.042 0.036 0.035
  τMB-BC,0.25 16.771 0.032 0.039 0.039 15.384 0.032 0.038 0.038 9.510 0.037 0.034 0.035 9.113 0.039 0.035 0.035
  τBVN, EE 165.037 0.215 0.214 0.215 84.101 0.140 0.143 0.144 486.221 0.125 0.125 0.123 294.818 0.083 0.109 0.108
  τMB-BC,EE,0.05 164.240 0.177 0.187 0.188 120.755 0.179 0.182 0.183 485.999 0.155 0.132 0.128 413.877 0.139 0.134 0.147
  τMB-BC,EE,0.25 163.967 0.172 0.184 0.185 120.842 0.176 0.177 0.178 486.146 0.120 0.128 0.124 413.966 0.117 0.129 0.142
Notes: Figures represent root mean squared errors.  Results based on 50 data sets with 250,000 observations each.  Specification (1) is under-specified (relevant higher order terms are excluded); specifica
(2) is correctly specified; specification (3) is over-specified (irrelevant higher order terms are included); specification (4) is over-specified (irrelevant higher order terms and an irrelevant variable are 
included).  Shading indicates best performance within each column.  See text and Table 1 for further details. 
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Table B2.  Monte Carlo Results: Estimates in the Common Effect Model ( ρ 0σ0 = -0.25; ρ01 = 1)
(1) (2) (3) (4) (1) (2) (3) (4) (1) (2) (3) (4) (1) (2) (3) (4)
I.  Normally Distributed Errors
  τHI 0.960 0.442 0.441 0.441 0.912 0.446 0.446 0.446 0.957 0.416 0.442 0.442 0.911 0.419 0.441 0.441
  τMB,0.05 0.707 0.399 0.398 0.398 0.577 0.398 0.399 0.399 0.630 0.426 0.401 0.400 1.072 0.425 0.401 0.400
  τMB,0.25 0.765 0.404 0.404 0.404 0.920 0.405 0.405 0.405 0.679 0.427 0.403 0.403 1.105 0.428 0.405 0.405
  τMB,EE,0.05 0.508 0.443 0.436 0.438 0.807 0.428 0.427 0.426 0.769 0.384 0.433 0.432 0.735 0.413 0.422 0.419
  τMB,EE,0.25 0.768 0.424 0.421 0.422 0.722 0.418 0.418 0.418 0.876 0.416 0.420 0.419 0.800 0.425 0.418 0.417
  τKV 3.310 0.048 0.054 0.054 3.310 0.048 0.054 0.054 3.237 0.039 0.043 0.043 3.237 0.039 0.043 0.043
  τBVN 15.671 0.036 0.040 0.040 10.410 0.116 0.120 0.120 8.983 0.089 0.049 0.050 6.225 0.168 0.131 0.132
  τMB-BC,0.05 15.136 0.040 0.043 0.042 13.604 0.037 0.040 0.039 8.463 0.113 0.051 0.051 8.176 0.118 0.053 0.053
  τMB-BC,0.25 15.194 0.038 0.043 0.043 13.948 0.036 0.040 0.040 8.512 0.114 0.052 0.052 8.210 0.120 0.053 0.053
  τBVN, EE 179.771 0.204 0.199 0.198 93.074 0.166 0.163 0.164 427.639 0.121 0.121 0.121 260.080 0.131 0.149 0.149
  τMB-BC,EE,0.05 179.642 0.306 0.309 0.302 134.008 0.199 0.197 0.199 427.429 0.165 0.131 0.124 364.700 0.153 0.176 0.177
  τMB-BC,EE,0.25 179.383 0.313 0.314 0.306 134.092 0.198 0.194 0.196 427.535 0.125 0.133 0.124 364.765 0.126 0.172 0.174
II.  Asymmetric, Non-Normally Distributed Errors
  τHI 0.920 0.379 0.379 0.379 0.868 0.346 0.346 0.346 0.920 0.365 0.391 0.391 0.870 0.336 0.355 0.355
  τMB,0.05 0.590 0.312 0.309 0.309 0.612 0.400 0.399 0.398 0.687 0.160 0.327 0.327 1.071 0.422 0.401 0.401
  τMB,0.25 0.697 0.323 0.324 0.324 0.926 0.383 0.383 0.383 0.735 0.294 0.337 0.337 1.102 0.405 0.382 0.382
  τMB,EE,0.05 0.474 0.318 0.316 0.314 0.674 0.315 0.333 0.337 1.034 0.128 0.325 0.325 0.652 0.242 0.350 0.334
  τMB,EE,0.25 0.716 0.332 0.332 0.332 0.623 0.326 0.333 0.335 1.175 0.294 0.337 0.337 0.742 0.302 0.345 0.339
  τKV 3.309 0.054 0.056 0.056 3.309 0.054 0.056 0.056 3.237 0.035 0.044 0.044 3.237 0.035 0.044 0.044
  τBVN 14.125 0.088 0.062 0.062 9.495 0.206 0.188 0.188 7.849 0.121 0.119 0.119 5.546 0.228 0.230 0.230
  τMB-BC,0.05 13.518 0.073 0.053 0.053 12.432 0.229 0.213 0.212 7.421 0.059 0.131 0.131 7.317 0.283 0.269 0.269
  τMB-BC,0.25 13.625 0.085 0.067 0.067 12.745 0.212 0.196 0.196 7.470 0.095 0.142 0.142 7.348 0.266 0.251 0.250
  τBVN, EE 194.729 0.223 0.220 0.220 101.804 0.185 0.187 0.187 407.323 0.131 0.110 0.108 248.174 0.127 0.157 0.156
  τMB-BC,EE,0.05 194.579 0.236 0.237 0.227 146.511 0.211 0.203 0.212 406.960 0.227 0.158 0.155 347.828 0.169 0.158 0.164
  τMB-BC,EE,0.25 194.338 0.243 0.249 0.232 146.561 0.219 0.199 0.207 407.101 0.141 0.168 0.165 347.918 0.113 0.156 0.168
Notes:  See Table B1.
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Table B3.  Monte Carlo Results: Estimates in the Common Effect Model ( ρ 0σ0 = -0.50; ρ01 = 1)
(1) (2) (3) (4) (1) (2) (3) (4) (1) (2) (3) (4) (1) (2) (3) (4)
I.  Normally Distributed Errors
  τHI 1.308 0.884 0.884 0.884 1.267 0.894 0.894 0.894 1.300 0.844 0.876 0.876 1.258 0.846 0.878 0.878
  τMB,0.05 1.098 0.801 0.801 0.800 0.959 0.799 0.800 0.799 1.033 0.825 0.801 0.801 1.400 0.819 0.802 0.801
  τMB,0.25 1.150 0.808 0.808 0.808 1.266 0.808 0.808 0.808 1.075 0.827 0.807 0.807 1.438 0.828 0.807 0.807
  τMB,EE,0.05 0.893 0.871 0.873 0.873 1.192 0.844 0.854 0.850 1.141 0.804 0.804 0.805 1.132 0.821 0.816 0.814
  τMB,EE,0.25 1.135 0.842 0.844 0.845 1.128 0.827 0.837 0.834 1.219 0.828 0.808 0.808 1.169 0.830 0.818 0.819
  τKV 3.309 0.053 0.057 0.058 3.309 0.053 0.057 0.058 3.239 0.043 0.055 0.055 3.239 0.043 0.055 0.055
  τBVN 13.982 0.035 0.038 0.038 9.453 0.221 0.221 0.221 8.065 0.156 0.065 0.065 5.751 0.325 0.247 0.248
  τMB-BC,0.05 13.527 0.038 0.039 0.039 12.180 0.036 0.038 0.037 7.631 0.180 0.067 0.067 7.400 0.188 0.067 0.066
  τMB-BC,0.25 13.580 0.038 0.040 0.040 12.487 0.037 0.039 0.039 7.672 0.182 0.070 0.071 7.438 0.197 0.070 0.070
  τBVN, EE 193.976 0.219 0.217 0.215 101.757 0.263 0.256 0.257 362.288 0.186 0.118 0.119 221.462 0.219 0.201 0.202
  τMB-BC,EE,0.05 193.871 0.288 0.293 0.260 146.741 0.225 0.236 0.220 362.089 0.228 0.129 0.129 309.975 0.165 0.131 0.135
  τMB-BC,EE,0.25 193.630 0.308 0.312 0.280 146.803 0.220 0.231 0.218 362.166 0.198 0.132 0.132 310.013 0.150 0.132 0.136
II.  Asymmetric, Non-Normally Distributed Errors
  τHI 1.144 0.624 0.624 0.624 1.083 0.485 0.485 0.485 1.148 0.638 0.668 0.668 1.088 0.510 0.531 0.531
  τMB,0.05 1.249 0.210 0.195 0.195 1.089 0.779 0.779 0.779 1.669 0.105 0.403 0.403 1.433 0.800 0.777 0.777
  τMB,0.25 1.325 0.369 0.369 0.369 1.237 0.715 0.715 0.715 1.503 0.381 0.433 0.433 1.418 0.731 0.714 0.714
  τMB,EE,0.05 0.703 0.238 0.241 0.241 0.686 0.210 0.209 0.211 1.666 0.113 0.289 0.290 0.813 0.104 0.324 0.287
  τMB,EE,0.25 0.919 0.374 0.373 0.373 0.754 0.353 0.352 0.353 1.502 0.382 0.421 0.421 0.958 0.362 0.420 0.410
  τKV 3.306 0.052 0.060 0.060 3.306 0.052 0.060 0.060 3.233 0.033 0.046 0.046 3.233 0.033 0.046 0.046
  τBVN 7.576 0.288 0.144 0.145 5.638 0.573 0.492 0.493 2.934 0.311 0.376 0.377 2.644 0.574 0.644 0.645
  τMB-BC,0.05 7.352 0.207 0.146 0.147 7.328 0.848 0.773 0.774 2.892 0.105 0.403 0.403 3.501 0.866 0.959 0.960
  τMB-BC,0.25 7.431 0.366 0.315 0.316 7.475 0.784 0.709 0.710 2.731 0.381 0.433 0.433 3.487 0.798 0.896 0.897
  τBVN, EE 248.396 0.215 0.220 0.218 133.438 0.224 0.221 0.224 308.049 0.158 0.162 0.164 189.241 0.265 0.287 0.289
  τMB-BC,EE,0.05 248.219 0.230 0.229 0.230 192.306 0.202 0.197 0.199 305.633 0.114 0.288 0.289 265.048 0.104 0.297 0.286
  τMB-BC,EE,0.25 248.003 0.359 0.354 0.356 192.237 0.340 0.335 0.336 305.469 0.366 0.420 0.420 265.192 0.351 0.428 0.409
Notes:  See Table B1.
Homoskedastic Error in Treatment Equation Heteroskedastic Error in Treatment Equation
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Table B4.  Monte Carlo Results: Estimates in the Heterogeneous Effect Model ( ρ 0σ0 = 0; ρ01 = 0.50; ρδσδ = 0)
(1) (2) (3) (4) (1) (2) (3) (4) (1) (2) (3) (4) (1) (2) (3) (4)
I.  Normally Distributed Errors
  τHI 0.614 0.006 0.006 0.006 0.560 0.007 0.007 0.007 0.616 0.014 0.010 0.010 0.566 0.009 0.008 0.008
  τMB,0.05 0.311 0.016 0.015 0.016 0.197 0.015 0.014 0.014 0.228 0.047 0.025 0.025 0.729 0.029 0.015 0.015
  τMB,0.25 0.380 0.008 0.008 0.007 0.590 0.006 0.006 0.006 0.282 0.023 0.013 0.013 0.772 0.025 0.007 0.007
  τMB,EE,0.05 0.278 0.017 0.017 0.017 0.424 0.016 0.017 0.018 0.397 0.095 0.027 0.027 0.341 0.095 0.028 0.028
  τMB,EE,0.25 0.534 0.010 0.009 0.009 0.330 0.009 0.010 0.009 0.537 0.023 0.014 0.013 0.432 0.031 0.013 0.013
  τKV 3.309 0.049 0.048 0.049 3.309 0.049 0.048 0.049 3.238 0.035 0.042 0.042 3.238 0.035 0.042 0.042
  τBVN 17.365 0.034 0.038 0.038 11.370 0.025 0.028 0.028 10.058 0.033 0.032 0.032 6.797 0.026 0.025 0.025
  τMB-BC,0.05 16.744 0.036 0.039 0.040 15.025 0.036 0.039 0.039 9.450 0.057 0.040 0.040 9.068 0.048 0.035 0.035
  τMB-BC,0.25 16.813 0.034 0.037 0.038 15.419 0.034 0.037 0.037 9.505 0.038 0.032 0.033 9.111 0.042 0.032 0.033
  τBVN, EE 166.554 0.161 0.169 0.170 84.849 0.108 0.120 0.121 489.627 0.096 0.118 0.117 296.878 0.069 0.103 0.102
  τMB-BC,EE,0.05 165.844 0.160 0.206 0.207 121.848 0.140 0.148 0.151 489.410 0.117 0.149 0.149 416.850 0.128 0.121 0.120
  τMB-BC,EE,0.25 165.567 0.158 0.203 0.204 121.942 0.139 0.147 0.150 489.550 0.080 0.142 0.141 416.943 0.092 0.114 0.113
II.  Asymmetric, Non-Normally Distributed Errors
  τHI 0.613 0.006 0.006 0.006 0.560 0.008 0.007 0.007 0.615 0.015 0.009 0.009 0.565 0.010 0.007 0.007
  τMB,0.05 0.313 0.016 0.017 0.016 0.197 0.017 0.016 0.016 0.226 0.083 0.020 0.021 0.728 0.027 0.016 0.016
  τMB,0.25 0.377 0.009 0.010 0.010 0.586 0.009 0.008 0.009 0.283 0.021 0.010 0.009 0.770 0.024 0.008 0.008
  τMB,EE,0.05 0.299 0.020 0.020 0.021 0.416 0.018 0.018 0.019 0.391 0.104 0.033 0.033 0.344 0.099 0.028 0.028
  τMB,EE,0.25 0.552 0.011 0.010 0.011 0.330 0.009 0.009 0.009 0.535 0.020 0.015 0.015 0.430 0.027 0.013 0.012
  τKV 3.309 0.056 0.074 0.074 3.309 0.056 0.074 0.074 3.236 0.041 0.059 0.059 3.236 0.041 0.059 0.059
  τBVN 17.273 0.043 0.047 0.047 11.312 0.033 0.035 0.035 10.112 0.035 0.049 0.049 6.832 0.026 0.037 0.037
  τMB-BC,0.05 16.654 0.045 0.048 0.048 14.946 0.050 0.052 0.051 9.501 0.088 0.052 0.053 9.114 0.045 0.053 0.053
  τMB-BC,0.25 16.718 0.042 0.046 0.046 15.335 0.045 0.047 0.047 9.559 0.041 0.048 0.047 9.157 0.042 0.047 0.047
  τBVN, EE 162.615 0.206 0.216 0.215 82.640 0.140 0.152 0.151 485.568 0.102 0.112 0.112 294.464 0.069 0.095 0.095
  τMB-BC,EE,0.05 161.783 0.191 0.214 0.200 118.670 0.183 0.191 0.197 485.350 0.135 0.153 0.153 413.432 0.116 0.121 0.120
  τMB-BC,EE,0.25 161.510 0.185 0.210 0.196 118.756 0.178 0.186 0.192 485.494 0.101 0.144 0.144 413.518 0.092 0.114 0.112
Notes:  See Table B1.
Homoskedastic Error in Treatment Equation Heteroskedastic Error in Treatment Equation
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Table B5.  Monte Carlo Results: Estimates in the Heterogeneous Effect Model ( ρ 0σ0 = -0.20; ρ01 = 0.50; ρδσδ = -0.10)
(1) (2) (3) (4) (1) (2) (3) (4) (1) (2) (3) (4) (1) (2) (3) (4)
I.  Normally Distributed Errors
  τHI 0.936 0.413 0.413 0.413 0.841 0.359 0.359 0.359 0.933 0.390 0.418 0.418 0.841 0.337 0.360 0.360
  τMB,0.05 0.628 0.383 0.383 0.383 0.515 0.309 0.310 0.309 0.655 0.411 0.382 0.383 0.985 0.335 0.310 0.310
  τMB,0.25 0.724 0.382 0.382 0.381 0.842 0.307 0.307 0.307 0.707 0.402 0.381 0.381 1.019 0.330 0.307 0.307
  τMB,EE,0.05 0.489 0.407 0.414 0.411 0.672 0.331 0.328 0.326 0.886 0.384 0.402 0.400 0.594 0.346 0.325 0.322
  τMB,EE,0.25 0.733 0.392 0.395 0.394 0.590 0.310 0.308 0.307 1.040 0.393 0.391 0.390 0.679 0.327 0.306 0.307
  τKV 3.306 0.039 0.060 0.060 3.263 0.060 0.062 0.062 3.230 0.048 0.061 0.061 3.188 0.084 0.095 0.094
  τBVN 14.491 0.036 0.046 0.046 9.661 0.095 0.094 0.094 8.278 0.085 0.045 0.045 5.760 0.144 0.104 0.104
  τMB-BC,0.05 13.908 0.042 0.049 0.050 12.606 0.039 0.048 0.048 7.806 0.119 0.049 0.049 7.558 0.103 0.040 0.040
  τMB-BC,0.25 14.004 0.037 0.046 0.046 12.933 0.036 0.046 0.046 7.859 0.109 0.046 0.046 7.594 0.097 0.037 0.038
  τBVN, EE 176.333 0.218 0.218 0.216 91.110 0.185 0.183 0.182 413.622 0.162 0.145 0.145 251.899 0.115 0.162 0.163
  τMB-BC,EE,0.05 176.203 0.240 0.275 0.270 131.159 0.223 0.216 0.220 413.388 0.177 0.166 0.136 353.104 0.187 0.209 0.209
  τMB-BC,EE,0.25 175.960 0.248 0.289 0.281 131.240 0.206 0.200 0.203 413.540 0.165 0.175 0.134 353.189 0.160 0.188 0.193
II.  Asymmetric, Non-Normally Distributed Errors
  τHI 0.904 0.376 0.376 0.376 0.802 0.281 0.281 0.281 0.904 0.362 0.389 0.389 0.817 0.285 0.304 0.304
  τMB,0.05 0.536 0.284 0.285 0.285 0.606 0.364 0.364 0.364 0.858 0.106 0.302 0.301 1.051 0.383 0.357 0.357
  τMB,0.25 0.644 0.297 0.297 0.297 0.890 0.344 0.344 0.344 0.870 0.268 0.310 0.310 1.068 0.359 0.337 0.337
  τMB,EE,0.05 0.456 0.304 0.307 0.309 0.606 0.269 0.297 0.305 1.080 0.118 0.312 0.301 0.590 0.269 0.313 0.332
  τMB,EE,0.25 0.691 0.312 0.315 0.316 0.561 0.271 0.282 0.284 1.183 0.268 0.315 0.310 0.688 0.264 0.287 0.294
  τKV 3.276 0.137 0.122 0.121 3.229 0.181 0.164 0.163 3.204 0.107 0.123 0.122 3.171 0.138 0.154 0.153
  τBVN 12.671 0.091 0.142 0.142 8.570 0.069 0.045 0.045 6.696 0.033 0.035 0.035 4.807 0.137 0.138 0.139
  τMB-BC,0.05 12.031 0.097 0.141 0.140 11.257 0.108 0.083 0.083 6.447 0.171 0.054 0.054 6.381 0.204 0.185 0.186
  τMB-BC,0.25 12.140 0.087 0.129 0.129 11.541 0.090 0.065 0.066 6.462 0.036 0.059 0.060 6.399 0.181 0.166 0.166
  τBVN, EE 208.984 0.259 0.263 0.264 109.793 0.182 0.187 0.188 394.018 0.146 0.106 0.106 240.460 0.116 0.134 0.136
  τMB-BC,EE,0.05 208.833 0.235 0.339 0.339 158.126 0.233 0.263 0.257 393.307 0.250 0.184 0.132 337.104 0.174 0.167 0.191
  τMB-BC,EE,0.25 208.599 0.230 0.350 0.349 158.169 0.225 0.246 0.234 393.411 0.144 0.204 0.137 337.203 0.126 0.133 0.143
Notes:  See Table B1.
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Table B6.  Monte Carlo Results: Estimates in the Heterogeneous Effect Model ( ρ 0σ0 = -0.40; ρ01 = 0.50; ρδσδ = -0.10)
(1) (2) (3) (4) (1) (2) (3) (4) (1) (2) (3) (4) (1) (2) (3) (4)
I.  Normally Distributed Errors
  τHI 1.214 0.767 0.767 0.767 1.125 0.717 0.716 0.716 1.207 0.733 0.765 0.765 1.119 0.678 0.708 0.708
  τMB,0.05 0.936 0.710 0.710 0.710 0.830 0.646 0.646 0.645 1.009 0.734 0.707 0.707 1.265 0.667 0.646 0.646
  τMB,0.25 1.027 0.710 0.711 0.711 1.118 0.642 0.642 0.642 1.049 0.736 0.709 0.709 1.297 0.661 0.642 0.642
  τMB,EE,0.05 0.802 0.766 0.772 0.772 0.987 0.679 0.682 0.683 1.107 0.719 0.713 0.712 0.924 0.669 0.649 0.649
  τMB,EE,0.25 1.027 0.737 0.738 0.739 0.919 0.652 0.651 0.653 1.222 0.733 0.713 0.712 0.984 0.660 0.641 0.641
  τKV 3.308 0.050 0.056 0.055 3.265 0.079 0.070 0.069 3.231 0.061 0.072 0.071 3.189 0.097 0.107 0.106
  τBVN 13.085 0.040 0.046 0.046 8.860 0.177 0.177 0.177 7.275 0.146 0.061 0.061 5.212 0.276 0.201 0.201
  τMB-BC,0.05 12.563 0.043 0.050 0.050 11.436 0.040 0.046 0.045 6.906 0.175 0.063 0.062 6.731 0.182 0.068 0.067
  τMB-BC,0.25 12.654 0.043 0.049 0.048 11.724 0.040 0.045 0.045 6.946 0.176 0.062 0.062 6.763 0.176 0.064 0.064
  τBVN, EE 190.273 0.211 0.209 0.209 99.565 0.208 0.214 0.214 369.806 0.186 0.126 0.126 225.825 0.174 0.186 0.186
  τMB-BC,EE,0.05 190.160 0.299 0.283 0.292 143.592 0.233 0.248 0.241 369.558 0.205 0.120 0.121 316.236 0.179 0.194 0.195
  τMB-BC,EE,0.25 189.935 0.324 0.303 0.317 143.660 0.235 0.243 0.236 369.672 0.186 0.117 0.118 316.295 0.152 0.180 0.181
II.  Asymmetric, Non-Normally Distributed Errors
  τHI 1.093 0.602 0.602 0.602 0.994 0.441 0.441 0.441 1.095 0.603 0.634 0.634 1.010 0.461 0.484 0.484
  τMB,0.05 1.131 0.282 0.282 0.282 0.998 0.691 0.691 0.691 1.609 0.145 0.338 0.339 1.358 0.722 0.698 0.699
  τMB,0.25 1.258 0.387 0.387 0.386 1.162 0.634 0.634 0.634 1.441 0.379 0.422 0.422 1.353 0.660 0.641 0.641
  τMB,EE,0.05 0.653 0.313 0.312 0.312 0.672 0.285 0.289 0.288 1.608 0.145 0.337 0.338 0.789 0.134 0.416 0.332
  τMB,EE,0.25 0.868 0.400 0.398 0.398 0.718 0.372 0.374 0.374 1.444 0.378 0.422 0.422 0.919 0.361 0.437 0.413
  τKV 3.248 0.227 0.202 0.201 3.211 0.264 0.238 0.237 3.177 0.150 0.164 0.164 3.152 0.175 0.189 0.188
  τBVN 7.656 0.067 0.199 0.199 5.628 0.259 0.183 0.183 3.075 0.074 0.125 0.125 2.684 0.343 0.397 0.397
  τMB-BC,0.05 7.369 0.119 0.231 0.231 7.339 0.456 0.383 0.383 3.091 0.112 0.224 0.225 3.580 0.583 0.645 0.646
  τMB-BC,0.25 7.500 0.048 0.133 0.133 7.504 0.400 0.326 0.326 2.927 0.136 0.307 0.307 3.576 0.520 0.588 0.588
  τBVN, EE 256.032 0.270 0.260 0.260 137.411 0.215 0.205 0.208 296.996 0.144 0.118 0.120 183.244 0.209 0.216 0.218
  τMB-BC,EE,0.05 255.865 0.252 0.248 0.248 197.951 0.222 0.228 0.228 294.303 0.138 0.286 0.288 256.301 0.125 0.283 0.284
  τMB-BC,EE,0.25 255.650 0.296 0.295 0.295 197.904 0.267 0.275 0.275 294.140 0.266 0.368 0.369 256.431 0.263 0.361 0.363
Notes:  See Table B1.
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Table C1.  Effect of SBP Participation on BMI Growth
Specification (1) Specification (2) Specification (3) Specification (1) Specification (2) Specification (3)
A.  ATE
  τOLS 0.008 0.008 0.008 0.441 0.524 0.523
[  0.004,  0.011] [  0.004,  0.012] [  0.005,  0.013] [ -0.596,  1.440] [ -0.397,  1.421] [ -0.356,  1.390]
  τHI 0.011 0.011 0.011 1.108 0.568 1.031
[  0.006,  0.016] [  0.006,  0.016] [  0.007,  0.016] [ -0.250,  2.117] [ -0.638,  2.016] [ -0.278,  2.096]
  τMB,0.05 0.007 0.012 0.016 1.768 -0.325 0.133
[ -0.007,  0.020] [ -0.004,  0.020] [ -0.005,  0.023] [ -2.505,  3.297] [ -2.615,  3.655] [ -2.805,  4.000]
  τMB,0.25 0.007 0.010 0.010 0.855 0.263 0.631
[  0.001,  0.012] [  0.002,  0.013] [  0.003,  0.015] [ -0.916,  1.772] [ -1.037,  2.038] [ -0.647,  1.951]
  τKV -0.041 -0.037 -0.037 -5.168 -0.287 -3.029
[ -0.064, -0.014] [ -0.060, -0.006] [ -0.063, -0.008] [ -9.681, -0.186] [ -6.138,  5.347] [ -8.575,  3.430]
  τBVN -0.045 -0.028 -0.032 -4.882 -1.301 -3.960
[ -0.069, -0.022] [ -0.054, -0.002] [ -0.052, -0.007] [-10.226,  0.329] [ -6.913,  3.918] [ -8.903,  2.686]
  τMB-BC,0.05 -0.044 -0.022 -0.022 -3.410 -1.682 -4.060
[ -0.075, -0.015] [ -0.054,  0.005] [ -0.053, -0.001] [ -9.916,  0.388] [ -7.331,  5.246] [ -9.292,  3.071]
  τMB-BC,0.25 -0.044 -0.024 -0.028 -4.323 -1.094 -3.563
[ -0.069, -0.019] [ -0.053,  0.003] [ -0.049,  0.002] [ -9.814,  0.670] [ -6.115,  3.779] [ -7.975,  2.609]
  P* 0.415 0.514 0.546 0.392 0.807 0.510
[  0.263,  0.704] [  0.216,  0.894] [  0.317,  0.925] [  0.080,  0.868] [  0.030,  0.923] [  0.057,  0.880]
B.  ATT
  τOLS 0.008 0.008 0.008 0.441 0.524 0.523
[  0.004,  0.011] [  0.004,  0.012] [  0.005,  0.013] [ -0.596,  1.440] [ -0.397,  1.421] [ -0.356,  1.390]
  τHI 0.009 0.009 0.008 0.558 0.431 0.555
[  0.004,  0.013] [  0.005,  0.014] [  0.004,  0.013] [ -0.418,  1.487] [ -0.578,  1.376] [ -0.393,  1.595]
  τMB,0.05 0.012 0.013 0.010 1.086 0.641 0.455
[  0.001,  0.024] [  0.001,  0.025] [ -0.001,  0.026] [ -1.907,  3.341] [ -1.974,  3.028] [ -2.412,  2.968]
  τMB,0.25 0.012 0.012 0.010 0.532 0.273 0.145
[  0.005,  0.016] [  0.006,  0.016] [  0.005,  0.016] [ -0.841,  1.884] [ -0.781,  1.523] [ -0.876,  1.479]
  τKV -0.041 -0.037 -0.037 -5.168 -0.287 -3.029
[ -0.064, -0.014] [ -0.060, -0.006] [ -0.063, -0.008] [ -9.681, -0.186] [ -6.138,  5.347] [ -8.575,  3.430]
  τBVN -0.014 -0.006 -0.007 -1.703 0.039 -1.152
[ -0.028, -0.003] [ -0.021,  0.007] [ -0.017,  0.007] [ -4.458,  0.988] [ -2.598,  2.718] [ -3.587,  2.258]
  τMB-BC,0.05 -0.043 -0.021 -0.026 -4.652 -0.404 -3.699
[ -0.077, -0.013] [ -0.054,  0.012] [ -0.050,  0.012] [-11.959,  2.261] [ -7.177,  6.872] [-10.352,  4.554]
  τMB-BC,0.25 -0.043 -0.022 -0.026 -5.206 -0.772 -4.008
[ -0.076, -0.016] [ -0.056,  0.007] [ -0.050,  0.007] [-11.844,  1.424] [ -6.610,  5.897] [-10.397,  4.814]
  P* 0.500 0.500 0.500 0.500 0.500 0.500
Fifth Grade Outcome
Notes: Treatment is defined as participation in SBP in first and third grades (first, third, and fifth grades) in Columns 1-3 (4-
6).  See Table 4 for more details.
Third Grade Outcome
Table C2.  Effect of SBP Participation on the Probability of Being Overweight
Specification (1) Specification (2) Specification (3) Specification (1) Specification (2) Specification (3)
A.  ATE
  τOLS 0.023 0.023 0.024 0.020 0.021 0.020
[  0.002,  0.045] [  0.001,  0.046] [  0.002,  0.044] [ -0.003,  0.042] [ -0.005,  0.045] [ -0.006,  0.045]
  τHI 0.038 0.037 0.037 0.029 0.035 0.031
[  0.009,  0.071] [  0.014,  0.066] [  0.008,  0.063] [  0.003,  0.063] [  0.005,  0.072] [ -0.003,  0.067]
  τMB,0.05 -0.025 -0.036 -0.005 0.033 0.087 0.100
[ -0.080,  0.063] [ -0.060,  0.078] [ -0.064,  0.081] [ -0.073,  0.123] [ -0.065,  0.122] [ -0.075,  0.141]
  τMB,0.25 -0.001 0.016 0.017 0.033 0.053 0.036
[ -0.028,  0.037] [ -0.017,  0.048] [ -0.019,  0.041] [ -0.019,  0.067] [ -0.020,  0.068] [ -0.012,  0.072]
  τKV -0.175 -0.176 -0.159 -0.219 -0.223 -0.228
[ -0.306, -0.032] [ -0.292, -0.006] [ -0.272,  0.020] [ -0.372, -0.079] [ -0.367, -0.057] [ -0.339, -0.048]
  τBVN -0.269 -0.227 -0.213 -0.282 -0.239 -0.255
[ -0.389, -0.148] [ -0.340, -0.084] [ -0.319, -0.059] [ -0.408, -0.146] [ -0.372, -0.079] [ -0.363, -0.099]
  τMB-BC,0.05 -0.309 -0.279 -0.233 -0.263 -0.165 -0.167
[ -0.430, -0.120] [ -0.352, -0.080] [ -0.349, -0.030] [ -0.392, -0.126] [ -0.369, -0.055] [ -0.373, -0.054]
  τMB-BC,0.25 -0.285 -0.227 -0.212 -0.263 -0.199 -0.230
[ -0.410, -0.139] [ -0.339, -0.081] [ -0.313, -0.052] [ -0.389, -0.133] [ -0.356, -0.048] [ -0.347, -0.063]
  P* 0.343 0.343 0.392 0.279 0.307 0.346
[  0.228,  0.639] [  0.196,  0.683] [  0.219,  0.760] [  0.139,  0.470] [  0.155,  0.676] [  0.167,  0.672]
B.  ATT
  τOLS 0.023 0.023 0.024 0.020 0.021 0.020
[  0.002,  0.045] [  0.001,  0.046] [  0.002,  0.044] [ -0.003,  0.042] [ -0.005,  0.045] [ -0.006,  0.045]
  τHI 0.030 0.030 0.024 0.035 0.028 0.024
[  0.004,  0.054] [  0.008,  0.053] [  0.002,  0.047] [  0.007,  0.061] [  0.000,  0.057] [ -0.006,  0.051]
  τMB,0.05 0.024 0.034 0.017 0.001 0.025 0.001
[ -0.034,  0.085] [ -0.031,  0.096] [ -0.033,  0.089] [ -0.049,  0.077] [ -0.075,  0.071] [ -0.079,  0.056]
  τMB,0.25 0.032 0.037 0.032 0.029 0.030 0.037
[ -0.005,  0.050] [  0.005,  0.063] [ -0.000,  0.057] [  0.003,  0.064] [ -0.001,  0.070] [ -0.002,  0.067]
  τKV -0.175 -0.176 -0.159 -0.219 -0.223 -0.228
[ -0.306, -0.032] [ -0.292, -0.006] [ -0.272,  0.020] [ -0.372, -0.079] [ -0.367, -0.057] [ -0.339, -0.048]
  τBVN -0.108 -0.091 -0.081 -0.116 -0.095 -0.099
[ -0.167, -0.045] [ -0.150, -0.019] [ -0.138, -0.004] [ -0.180, -0.053] [ -0.164, -0.007] [ -0.158, -0.017]
  τMB-BC,0.05 -0.307 -0.249 -0.236 -0.374 -0.282 -0.309
[ -0.454, -0.138] [ -0.415, -0.073] [ -0.371, -0.034] [ -0.539, -0.175] [ -0.484, -0.079] [ -0.465, -0.119]
  τMB-BC,0.25 -0.299 -0.245 -0.221 -0.345 -0.277 -0.273
[ -0.446, -0.149] [ -0.395, -0.080] [ -0.347, -0.031] [ -0.493, -0.180] [ -0.448, -0.060] [ -0.427, -0.058]
  P* 0.500 0.500 0.500 0.500 0.500 0.500
Notes: Overweight is defined as BMI above the 85th percentile.  For other details, see Table C1.
Third Grade Outcome Fifth Grade Outcome
Table C3.  Effect of SBP Participation on the Probability of Being Obese
Specification (1) Specification (2) Specification (3) Specification (1) Specification (2) Specification (3)
A.  ATE
  τOLS 0.013 0.014 0.015 0.018 0.020 0.019
[ -0.002,  0.029] [ -0.002,  0.031] [ -0.003,  0.035] [ -0.005,  0.040] [ -0.000,  0.041] [ -0.004,  0.042]
  τHI 0.024 0.030 0.026 0.037 0.044 0.041
[  0.004,  0.052] [  0.010,  0.060] [  0.005,  0.049] [  0.010,  0.067] [  0.017,  0.075] [  0.013,  0.073]
  τMB,0.05 0.011 0.003 0.023 0.033 -0.004 -0.008
[ -0.058,  0.060] [ -0.041,  0.066] [ -0.049,  0.071] [ -0.049,  0.092] [ -0.059,  0.112] [ -0.063,  0.096]
  τMB,0.25 0.008 0.010 0.022 0.022 0.028 0.019
[ -0.024,  0.032] [ -0.014,  0.034] [ -0.019,  0.043] [ -0.014,  0.053] [ -0.008,  0.058] [ -0.019,  0.044]
  τKV -0.176 -0.141 -0.134 -0.235 -0.197 -0.194
[ -0.277, -0.061] [ -0.230, -0.003] [ -0.214, -0.007] [ -0.340, -0.121] [ -0.294, -0.068] [ -0.298, -0.050]
  τBVN -0.267 -0.196 -0.196 -0.274 -0.206 -0.236
[ -0.363, -0.161] [ -0.268, -0.083] [ -0.274, -0.060] [ -0.384, -0.163] [ -0.309, -0.080] [ -0.322, -0.077]
  τMB-BC,0.05 -0.260 -0.199 -0.179 -0.249 -0.215 -0.246
[ -0.373, -0.137] [ -0.288, -0.065] [ -0.282, -0.056] [ -0.388, -0.136] [ -0.309, -0.023] [ -0.329, -0.055]
  τMB-BC,0.25 -0.263 -0.193 -0.180 -0.260 -0.183 -0.219
[ -0.362, -0.157] [ -0.272, -0.066] [ -0.268, -0.049] [ -0.369, -0.139] [ -0.300, -0.017] [ -0.302, -0.043]
  P* 0.388 0.403 0.427 0.434 0.526 0.514
[  0.237,  0.570] [  0.234,  0.754] [  0.219,  0.766] [  0.272,  0.707] [  0.296,  0.914] [  0.303,  0.899]
B.  ATT
  τOLS 0.013 0.014 0.015 0.018 0.020 0.019
[ -0.002,  0.029] [ -0.002,  0.031] [ -0.003,  0.035] [ -0.005,  0.040] [ -0.000,  0.041] [ -0.004,  0.042]
  τHI 0.018 0.017 0.013 0.029 0.025 0.021
[  0.001,  0.037] [ -0.000,  0.036] [ -0.006,  0.033] [  0.003,  0.054] [  0.002,  0.048] [ -0.006,  0.045]
  τMB,0.05 0.023 0.026 0.021 -0.010 0.005 -0.013
[ -0.032,  0.065] [ -0.028,  0.074] [ -0.029,  0.071] [ -0.061,  0.075] [ -0.057,  0.067] [ -0.065,  0.062]
  τMB,0.25 0.022 0.023 0.023 0.022 0.021 0.023
[ -0.002,  0.039] [ -0.003,  0.043] [ -0.001,  0.050] [ -0.001,  0.056] [ -0.007,  0.055] [ -0.008,  0.051]
  τKV -0.176 -0.141 -0.134 -0.235 -0.197 -0.194
[ -0.277, -0.061] [ -0.230, -0.003] [ -0.214, -0.007] [ -0.340, -0.121] [ -0.294, -0.068] [ -0.298, -0.050]
  τBVN -0.109 -0.077 -0.075 -0.095 -0.063 -0.076
[ -0.158, -0.060] [ -0.117, -0.018] [ -0.123, -0.006] [ -0.153, -0.040] [ -0.118,  0.008] [ -0.124, -0.001]
  τMB-BC,0.05 -0.278 -0.195 -0.194 -0.309 -0.202 -0.248
[ -0.410, -0.149] [ -0.295, -0.040] [ -0.315, -0.025] [ -0.449, -0.147] [ -0.335, -0.034] [ -0.347, -0.035]
  τMB-BC,0.25 -0.279 -0.198 -0.193 -0.277 -0.185 -0.212
[ -0.391, -0.157] [ -0.294, -0.056] [ -0.302, -0.037] [ -0.409, -0.119] [ -0.332, -0.007] [ -0.317, -0.029]
  P* 0.500 0.500 0.500 0.500 0.500 0.500
Notes: Obese is defined as BMI above the 95th percentile.  For other details, see Table C1.
Third Grade Outcome Fifth Grade Outcome
Table C4.  Effect of SBP Participation on the Probability of Being Underweight
Specification (1) Specification (2) Specification (3) Specification (1) Specification (2) Specification (3)
A.  ATE
  τOLS -0.020 -0.021 -0.020 -0.017 -0.018 -0.017
[ -0.031, -0.009] [ -0.030, -0.009] [ -0.030, -0.008] [ -0.029, -0.005] [ -0.030, -0.005] [ -0.029, -0.005]
  τHI -0.026 -0.025 -0.025 -0.032 -0.027 -0.025
[ -0.040, -0.015] [ -0.036, -0.012] [ -0.037, -0.010] [ -0.044, -0.016] [ -0.039, -0.012] [ -0.036, -0.010]
  τMB,0.05 -0.016 -0.018 -0.021 0.006 0.000 -0.004
[ -0.058,  0.018] [ -0.064,  0.024] [ -0.065,  0.026] [ -0.053,  0.030] [ -0.058,  0.030] [ -0.059,  0.031]
  τMB,0.25 -0.017 -0.016 -0.016 -0.010 -0.011 -0.011
[ -0.038,  0.001] [ -0.042, -0.001] [ -0.040, -0.000] [ -0.030,  0.003] [ -0.039,  0.006] [ -0.041,  0.006]
  τKV -0.007 -0.018 0.003 0.091 0.036 0.054
[ -0.085,  0.078] [ -0.107,  0.073] [ -0.095,  0.100] [ -0.003,  0.200] [ -0.090,  0.134] [ -0.066,  0.145]
  τBVN 0.018 0.002 0.016 0.115 0.048 0.054
[ -0.058,  0.107] [ -0.098,  0.087] [ -0.082,  0.104] [  0.019,  0.222] [ -0.061,  0.147] [ -0.056,  0.146]
  τMB-BC,0.05 0.019 -0.003 0.010 0.129 0.054 0.055
[ -0.072,  0.118] [ -0.095,  0.102] [ -0.088,  0.110] [  0.003,  0.210] [ -0.067,  0.150] [ -0.066,  0.149]
  τMB-BC,0.25 0.017 0.000 0.015 0.113 0.042 0.048
[ -0.061,  0.105] [ -0.096,  0.096] [ -0.079,  0.104] [ -0.004,  0.216] [ -0.061,  0.143] [ -0.056,  0.137]
  P* 0.679 0.880 0.711 0.577 0.793 0.747
[  0.034,  0.961] [  0.028,  0.925] [  0.038,  0.897] [  0.350,  0.948] [  0.056,  0.977] [  0.032,  0.971]
B.  ATT
  τOLS -0.020 -0.021 -0.020 -0.017 -0.018 -0.017
[ -0.031, -0.009] [ -0.030, -0.009] [ -0.030, -0.008] [ -0.029, -0.005] [ -0.030, -0.005] [ -0.029, -0.005]
  τHI -0.020 -0.017 -0.017 -0.020 -0.013 -0.011
[ -0.034, -0.006] [ -0.030, -0.003] [ -0.031, -0.005] [ -0.039, -0.004] [ -0.028,  0.002] [ -0.025,  0.002]
  τMB,0.05 -0.014 -0.024 -0.026 -0.019 -0.042 -0.042
[ -0.062,  0.019] [ -0.060,  0.024] [ -0.057,  0.021] [ -0.062,  0.020] [ -0.059,  0.025] [ -0.062,  0.018]
  τMB,0.25 -0.015 -0.018 -0.015 -0.009 -0.012 -0.015
[ -0.030,  0.000] [ -0.029,  0.002] [ -0.030,  0.002] [ -0.028,  0.006] [ -0.031,  0.008] [ -0.029,  0.007]
  τKV -0.007 -0.018 0.003 0.091 0.036 0.054
[ -0.085,  0.078] [ -0.107,  0.073] [ -0.095,  0.100] [ -0.003,  0.200] [ -0.090,  0.134] [ -0.066,  0.145]
  τBVN -0.003 -0.012 -0.004 0.044 0.008 0.012
[ -0.047,  0.049] [ -0.070,  0.044] [ -0.061,  0.052] [ -0.012,  0.105] [ -0.055,  0.068] [ -0.052,  0.066]
  τMB-BC,0.05 0.015 -0.013 0.000 0.097 0.000 0.007
[ -0.084,  0.118] [ -0.124,  0.116] [ -0.100,  0.122] [ -0.028,  0.220] [ -0.099,  0.138] [ -0.112,  0.144]
  τMB-BC,0.25 0.015 -0.007 0.012 0.106 0.029 0.034
[ -0.076,  0.113] [ -0.111,  0.108] [ -0.095,  0.116] [ -0.010,  0.226] [ -0.091,  0.154] [ -0.090,  0.142]
  P* 0.500 0.500 0.500 0.500 0.500 0.500
Notes: Underweight is defined as BMI below the 20th percentile.  For other details, see Table C1.
Third Grade Outcome Fifth Grade Outcome
